α7β1 integrin regulation of skeletal muscle growth in response to mechanical stimulation by Mahmassani, Ziad S.
	  	  	  	  	  
α7β1 INTEGRIN REGULATION OF SKELETAL MUSCLE GROWTH IN RESPONSE TO 
MECHANICAL STIMULATION 
 
 
 
 
 
 
BY 
 
ZIAD MAHMASSANI 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Kinesiology 
in the Graduate College of the  
University of Illinois at Urbana-Champaign 2017 
 
 
 
 
Urbana, Illinois 
 
 
 
Doctoral Committee: 
  
 Associate Professor Marni Boppart, Chair 
Assistant Professor Nicholas Burd 
Associate Professor Kenneth Wilund 
Associate Professor Troy Hornberger, University of Wisconsin 
 
 
	   ii 
ABSTRACT 
The α7β1 integrin has been proposed to serve as a mechanosensor and essential regulator of 
myofiber remodeling given its localization at the membrane and primary role in adhering the 
outer extracellular matrix to the inner actin cytoskeleton. However, additional work is necessary 
to affirm a primary role for the α7 integrin subunit in the regulation of skeletal muscle mass. The 
purpose of this dissertation was to 1) use gene expression profiling to reveal potential 
mechanisms by which the α7BX2 integrin can promote an increase in muscle mass post-
eccentric exercise, 2) determine the extent to which the α7BX2 integrin contributes to an 
increase in muscle mass after chronic overload, and 3) determine the extent to which α7 integrin 
overexpression or integrin ligand (laminin-111, LM-111) binding can improve the anabolic 
response to loading in aged mice. Aim 1 used microarray analysis using RNA extracted from 
skeletal muscle of wild type (WT) or transgenic mice (MCK:α7BX2 integrin; α7Tg), under 
sedentary conditions and 3 hrs after an acute bout of downhill running. The results suggest that 
the α7β1 integrin initiates transcription of genes that allow for protection from stress and 
modulation of protein synthesis, both which may contribute to positive adaptations in skeletal 
muscle with mechanical stimulation.  In Aim 2, WT and α7Tg mice were subjected to 
myotenectomy (MTE) of the gastrocnemius muscles and subsequent chronic mechanical loading 
(CML) for 1 day (1D) or 14 days (14D).  The results suggest that the α7β1 integrin augments 
muscle mass and adaptation, and several changes may account for this observation, including a 
reduction in damage and stress, yes-associated protein (YAP) content, and increased phospho-
4E-BP1 on Ser65.  In Aim 3, α7Tg overexpression was not sufficient to rescue the anabolic 
response to chronic loading in aged mice, yet injection of LM-111 significantly restored integrin 
localization at the membrane and the anabolic response to a mechanical stimulus. Overall, the 
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studies in this dissertation suggest that the α7β1 integrin is an important regulator of muscle 
remodeling that leads to an increase in mass in response to mechanical strain, and that 
manipulation of the extracellular matrix within the microenvironment may provide a novel 
approach towards maintenance of mechanosensing and the anabolic response across the lifespan.  
These observations in mice provide impetus for assessment of the relationship between 
extracellular matrix protein composition and subsequent α7β1 integrin-mediated remodeling 
within human skeletal muscle. 
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CHAPTER 1 
LITERATURE REVIEW 
1.1 Introduction 
Skeletal muscle hypertrophy can occur via a variety of changes in muscle protein 
synthesis or breakdown rates; however, increased synthesis of myofibrillar protein is generally 
viewed as the major driver of protein accretion and increased muscle mass.  There are three 
distinct anabolic stimuli known to activate myofiber intracellular signaling and remodeling, 
including growth factors, amino acid ingestion, and mechanical stimulation (46).  While these 
anabolic stimuli possess unique and independent signaling machinery, some of these pathways 
are redundant and thus permissive and synergistic for maximal stimulation of protein synthesis 
(65).  The specific mechanisms leading to skeletal muscle remodeling under each condition are 
complex and not completely understood, however, in the context of skeletal muscle growth the 
end result is increased protein translation and abundance (64).  Mechanostumilation is the least 
understood of these three distinct anabolic stimuli.  
1.2 The Mammalian Target of Rapamycin 
The mammalian target of rapamycin (mTOR) is currently regarded as the central 
regulator of hypertrophic signaling (46, 64, 65, 70).  Early experiments in the field of skeletal 
muscle physiology have determined that all three hypertrophic stimuli converge through 
activation of this kinase, which has been extensively studied and characterized in the context of 
protein translation and cellular growth (46, 64) (Figure 1.1).  Much of what is known about the 
activation of mTOR comes from studying the growth factor/insulin stimulated arm of 
hypertrophic signaling, and these studies have been used to characterize downstream events 
involved in translation (64).    
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mTOR consists of two complexes, mTORC1 and mTORC2. mTORC1 is rapamycin 
sensitive and experimentation has implicated this complex to be activated by hypertrophic 
stimuli and regulatory of protein synthesis, whereas mTORC2 is rapamycin insensitive, and may 
not be necessary for activation of protein synthesis by hypertrophic stimuli (32, 46, 64, 65, 70).  
The mTORC1 complex consists 
of mTOR, Raptor, PRAS40, 
Deptor, and G protein beta 
subunit- like/mTOR associated 
protein, LST8 homolog 
(GβL/mLST8) (32, 46, 64, 65).  
Raptor is a positive regulator of 
mTORC1 signaling, and provides 
a scaffold for the mTORC1 
complex while also regulating 
downstream mTOR substrate phosphorylation. Conversely, PRAS40 and Deptor are negative 
regulators of mTOR. In addition, mTOR can be inhibited by the immunosuppressant drug 
rapamycin and the tuberous sclerosis complex 2 (TSC2). 
Growth factors, including insulin, strongly activate mTOR, but low concentrations of 
these peptide hormones are permissive for optimal activation of mTOR in the context of amino 
acid ingestion and mechanical stimulation (65).  Protein kinase B (PKB/AKT) is a central 
regulator of hypertrophy via growth factor stimulation.  AKT phosphorylation can dissociate 
PRAS40 from the mTOR complex, lessening its inhibitory effects and thus increasing protein 
translation in a growth factor/insulin dose dependent manner (32, 46, 48, 64, 65).  AKT can also 
Figure 1.1: Schematic of mTOR and its upstream regulators.  
There are three distinct hypertrophic stimuli: Nutrients (Amino 
Acids), Growth Factors, and Mechanical Stimulation (46). 
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phosphorylate and prevent TSC2 GTPase activity, which allows activation of mTOR by Ras 
homolog enriched in brain (Rheb) (46, 48, 64, 70).  AKT not only prevents TSC activity, but also 
sequesters TSC2 at the cell membrane, providing an additional layer of protection from 
inhibition (49).  Localization of the mTORC1 complex appears to be an important mechanism 
for regulation of activity, as both amino acid ingestion and mechanical stimulation can initiate 
the translocation of mTORC1 to the late endosome/early lysosome (LEL), providing maximal 
spatial distribution and protection from TSC inhibition (49, 54, 72, 73).  
1.3 Ribosome Assembly and Protein Translation 
Downstream of mTOR, kinase substrates 4E-BP1 and p70S6K regulate the efficiency of 
protein translation, as well as 
stimulation of rRNA synthesis and 
subsequent capacity for protein 
translation (45, 46, 64, 79) (Figure 
1.2).  Protein synthesis occurs at the 
ribosome through translation of 
mRNA, which is the blue print that 
guides the coordination of protein 
synthesis through the stringing 
together of amino acid sequences by 
tRNA, to form the peptide chains 
that make up a protein (64). Synthesis of myofibrillar protein occurs through the association and 
assembly of the 40s and 60s ribosome subunits(s) with tRNA and proteins called eukaryotic 
Figure 1.2: Schematic of mTOR downstream substrates.  
Activation of mTOR results in phosphorylation of 4E-BP1 and 
p70S6K.  This increases protein synthesis, ribosomal biogenesis, 
and muscle growth. (70). 
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initiation factors (eIFs), in a process called cap-dependent translation (64). The three steps of 
cap-dependent translation are initiation, elongation, and termination.   
Ribosome assembly and initiation are subject to regulation by mTOR signaling pathway, 
and occur in multiple steps (Figure 1.3).  A ribosomal 43s pre-initiation complex (PIC) forms 
through assembly of eIF2 with the 40s subunit, while a separate eIF4F complex is formed  
 
through assembly of its subcomponents, eIF4E, eIF4G, and eIF4A (64).  The eIF4F, and 43s 
complexes associate together to form the 48s PIC, which then is able to scan for an initiation 
codon on the mRNA to begin protein synthesis.  The 48s PIC assembles with the 60s by eIF2.  
Figure 1.3: Assembly of the 80s ribosome.  The 40s and 60s ribosome subunits assemble with 
RNA and eIFs to initiate cap-dependent translation.  The result is increased protein synthesis (64). 
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This assembly is driven by eIF2B, which is a subcomponent of eIF2 that exchanges GDP for 
GTP, thus powering this final step of 80s ribosome assembly (64).  
Elongation is the step of translation in which amino acids are added to the peptide chain, 
and this step is also subject to regulation by the hypertrophic signaling pathway through 
modifications in eukaryotic elongation factor (eEF) activity (64).  Amino acids are recognized by 
sequences on the mRNA, and shuttled to the ribosome by tRNA in a two-step process.  The 
ribosome contains 3 binding sites, 2 of which are occupied at any one time.  The first step is the 
shift of the tRNA to a different binding site on the ribosome, and the second step is the eEF2-
GTP mediated movement of the mRNA by one codon (64).  The activity of eEF2 is inhibited by 
phosphorylation by eEF2 kinase (eEF2K) (64).  Termination is the final step of translation, 
which involves the release of the synthesized polypeptide from the tRNA, the release of tRNA 
from the ribosome, and the separation of the two ribosomal subunits from the mRNA (64). 
 When protein synthesis is not necessary, ribosome assembly and initiation are inhibited 
through the binding of 4E-BP1 to eIF4E, thus preventing formation of the eIF4F complex.  The 
phosphorylation of 4E-BP1 on both Serine 65 and Threonine 70 release this inhibition (64).  
Phosphorylation of 4E-BP1 on Threonine 37/46 by mTOR primes phosphorylation on Threonine 
70, which finally allows for phosphorylation on Serine 65.  Phosphorylation on Serine 65 is also 
primed by phosphorylation on a rarely studied residue, Serine 101, by upstream kinases other 
than mTOR (64). Conversely, negative regulation of 4E-BP1 phosphorylation and translation can 
occur via reduction in mTOR activity and increased stress mediated phosphatase activity (21). 
Activation of p70S6K (Thr389 by mTOR and Thr229 by a protein called PDK1), allows 
for downstream phosphorylation of eEF2K and ribosomal protein S6, which is a component of 
the 40s ribosome.  This results in relief of eEF2 inhibition, and enhanced ribosomal biogenesis, 
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respectively (64).  Activation of p70S6K requires phosphorylation of Thr389 (mTORC1) and 
Ser371, the latter of which is regulated by an unknown kinase (64).  Phosphorylation of a 
pseudo-substrate auto-inhibitory domain on p70S6K (Phosphorable sites: Ser411, Ser418, 
Thr421, and Ser424) promotes full activity of p70S6K and this event is partially rapamycin 
insensitive (64, 66). Activation of p70S6K and its downstream substrate S6 appear to be 
important for ribosomal biogenesis, yet the full repertoire of upstream regulators necessary for 
activation have not been revealed.    
Overall, the information presented above outlines the regulation of protein translation in 
skeletal muscle, including events that may occur independent of mTORC1.  Although not a 
complete list, there is evidence in the literature to suggest that any of the following signaling 
events enhance protein translation in a manner that is fully or partially independent of mTOR 
activation: Vps34 activation, eIF4F/PIC formation, eEF2K activity, eIF4B activation, and 
formation of phosphatidic acid (PA) (32, 46, 63, 64, 65).  There is also evidence to suggest that 
stress responsive mitogen-activated protein kinase (MAPK) and Hippo pathways, modulate 
translation through alternate mechanisms that do not require 4E-BP1 or p70S6K activation (32, 
34, 64, 86). 
1.4 Mechanosensing Pathways Leading to Skeletal Muscle Growth 
Mechanosensors are defined as transmembrane or intracellular elements, which detect 
and convert a mechanical stimulus into a chemical cue that can mediate an adaptive response, 
including myofibrillar protein synthesis.  Potential mechanosensors in skeletal muscle that 
contribute to protein translation and muscle growth include: release of growth factors (IGF-1), 
phospholipase D (PLD) and diacylglycerol kinase ζ (DGKζ), stretch-activated calcium channels, 
amino acid transporters, focal adhesion complex (FAC), and the α7β1 integrin (32, 34, 46, 48, 50, 
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70, 86).  The extent to which these factors serve as true mechanosensors, and the extent to which 
they rely on mTOR activation to increase protein synthesis is not fully understood. Seminal 
experiments that identified a role for mTOR in the response to mechanical stimulation include 
the observation by Baar and Esser in 1999 that activation of p70S6K correlated strongly with 
hypertrophy after resistance exercise, and the observation by Bodine et al., in 2001 that the 
mTOR inhibitor rapamycin prevents p70S6K activation and the increase in muscle mass 
following mechanical overload (2, 9, 46).  Goodman et al. subsequently provided strong 
evidence to suggest that mTOR kinase activity is necessary for the increase in muscle mass in 
response to mechanical strain (35). However, the mTOR inhibitor rapamycin may have non-
specific effects on the muscle fiber that may interfere with additional downstream signaling and 
mechanisms that promote protein translation. Thus, this section of the literature review will focus 
on mechanosensors that promote muscle growth in response to an appropriate mechanical load. 
While some mechanosensors are purported to require mTOR signaling, others do not.  
Release of growth factors (IGF-1) 
Stretch results in the synthesis and release of IGF-1 within skeletal muscle that activates 
the AKT-mTORC1 pathway in an autocrine/paracrine manner (70).  The initial paradigm for 
strain-induced protein synthesis was believed to occur through this mechanism until Goldberg et 
al. observed that an increase in muscle mass could occur in response to overload in 
hypophysectomized rats (33).  This paradigm was further scrutinized in 2008 when Spangenburg 
demonstrated load-induced activation of AKT, p70S6K and increased mass in mice that 
expressed a mutant IGF-1 receptor in skeletal muscle (70, 77).  While IGF-1 signaling may 
contribute to load-induced increases in muscle mass, it does not appear to be necessary. 
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Phospholipase D (PLD) and diacylglycerol kinase ζ (DGKζ) 
Mechanical stimulation enhances PLD and DGK activity and overexpression of DGKζ is 
sufficient to increase skeletal muscle hypertrophy (46, 48, 50, 91).  PLD and DGKζ are enzymes 
that synthesize phosphatidic acid (PA), a direct activator of mTOR signaling. Thus, PA 
accumulation and subsequent activation of mTOR signaling may significantly contribute 
increased mass following a mechanical stimulus (48, 50, 65).  PLD activity is transient and falls 
to baseline despite the continued rise in PA concentration. In addition, DGKζ knockout inhibits 
much of the increase in PA and mTORC1 activation with mechanical load (91). Thus, it is 
hypothesized that PLD is responsible for the initial increase in PA, whereas DGKζ is the critical 
regulator of PA and remodeling (91).   
Stretch-activated calcium channel 
Alterations in the conformation of the calcium (Ca2+) channel by strain can allow for the 
accumulation of calcium and induction of p70S6K activity (46, 64, 70, 76, 78). Spangenburg et 
al. has demonstrated that inhibition of calcium channel function results in a blunted p70S6K 
response (76, 88).  In the absence of exercise, artificially increasing Ca2+ concentrations 
increases protein synthesis and degradation in much the same pattern as resistance exercise (53, 
70).   
The precise mechanism by which Ca2+ can enhance growth is not known, yet may 
involve activation of the Ca2+-calmodulin signaling pathway (Figure 1.4).  Calmodulin is an 
intracellular sensor of Ca2+, and binding with Ca2+ allows for downstream activation of 
calcineurin, which then dephosphorylates nuclear factor of activated T cells (NFAT) resulting in 
translocation to the nucleus (67, 78).  NFAT acts as a transcription factor, altering RNA 
expression in a manner that can promote the slow twitch fiber phenotype.  Calcineurin inhibition 
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not only attenuates slow twitch fiber 
conversion, but can also blunt the 
hypertrophic response to mechanical 
overload (26, 78).  Additional 
experiments have implicated 
calcineurin as important for muscle 
growth in both type I and type II 
fibers (7, 26).  Cyclosporin A also 
results in attenuation of hypertrophy 
of both fiber types, although it is not 
clear if this observation is due to 
specific inhibition of calcineurin or 
the general anti-inflammatory properties of this natural product (7, 78). Finally, the vesicular 
transport protein Vps34 can sequester mTOR at the LEL (46).  The calmodulin binding site on 
Vps34 suggests capacity for regulation by Ca2+ and downstream activation of calcineurin. 
However, Vps34 interaction with calcium is questionable and there is evidence to suggest it may 
not be necessary for hypertrophy (46).  While the Ca2+-calmodulin complex can be activated by 
mechanical stimulation, the impact of mechanical strain and Ca2+ stimulation are additive for 
increased muscle mass, suggesting the existence of a distinct strain-mediated hypertrophic 
signaling pathway (46, 53, 70). 
Enhancement of amino acid transport 
Amino acid transport and accumulation in the myofiber may serve as a mechanosensor 
based on correlations between stretch-activated amino acid uptake and protein synthesis (33, 83). 
Figure 1.4: Mechanotransduction and calcium concentration.  
Increased calcium concentrations encourage binding with 
calmodulin, activating calcineurin.  This leads to nuclear 
translocation of NFAT (78).   
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The LAT1 amino acid transporter is a heterodimer consisting of SLC7A5 and SLC3A2 subunits. 
In vivo, SLC7A5 mRNA and protein content are increased in response to resistance exercise, 
resulting in elevated transporter expression and amino acid permeability 6h post exercise in 
humans, and 90 min post exercise in rats (8, 25, 63).  Currently, further experiments are 
necessary to determine the precise contribution of LAT1 expression and transporter activity to 
exercise-mediated increases in muscle mass. 
Focal adhesion complex 
Integrins are transmembrane protein heterodimers 
consisting of α and β subunits.  Eighteen unique α subunits, 
and 8 unique β units have been identified, resulting in the 
formation of at least 24 heterodimers in a wide variety of 
mammalian cell types.  Upon binding to the preferential ligand 
within the ECM, the integrin will undergo a conformational 
change in a manner that allows for the association of several 
proteins, including vinculin, α-actinin, talin, integrin linked 
kinase (ILK) and focal adhesion kinase (FAK) (Figure 1.5). 
Together, the integrin and its associated proteins develop the 
focal adhesion complex (FAC) that links the internal 
cytoskeleton of cells with the surrounding extracellular matrix.  The purpose of the FAC is to 
transmit force produced by contraction outward to the ECM, as well as transmit mechanical 
strain from the outside in.  ILK and FAK are primary sensors of integrin activation (29).  ILK 
can phosphorylate numerous downstream targets including integrin β1 cytoplasmic domain, 
AKT and GSK-3 (allowing for modulation of growth factor signaling), and PINCH and LIM-
Integrin 
 β 
 α 
Extracellular Matrix 
Sarcolemma 
Actin Cytoskeleton 
Z-band 
Talin 
Vinculin 
α-Actinin 
Focal Adhesion Kinase (FAK) 
Integrin-Linked Kinase (ILK) 
Figure 1.5: The focal adhesion 
complex.  Integrins associate with 
FAC proteins to bind the actin 
cytoskeleton inside the myofiber 
to the surrounding extracellular 
matrix. 
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domain protein (allowing for cell migration and spreading) (4, 23, 42, 80, 81).  Overexpression 
of ILK activates p70S6K in cardiac muscle and is correlated with increased mass in response to 
chronic overload (19, 60). 
The downstream targets of FAK regulate cell adhesion and migration, and actin 
cytoskeletal organization (47, 75).  Phosphorylated FAK can associate with PI3K and activate 
Grb7, as well as complex with Src phosphorylating p130cas and Crk, which are essential to cell 
migration as well as precede integrin mediated stress fiber formation (17, 18, 20, 41, 47, 55). 
FAK also phosphorylates paxillin, an important FAC protein that assists with costamere 
formation and stability (15, 82).  Early studies demonstrate that FAK overexpression can 
increase p70S6K (S411/T421) 6-24 hours following hindlimb suspension and reload, as well as 
induce a small increase in 
Type 1 myofiber CSA during 
normal weight bearing (28, 
56).  
The yes-associated 
protein (YAP) is a 
transcriptional co-activator 
expressed in a variety of 
mammalian cells that is 
strongly associated with 
tissue growth in a manner 
that is dependent on cell 
attachment. YAP is normally retained in an inactive state in the cytoplasm or is targeted for 
YAP 
YAP YAP 
YAP 
YAP 
Figure 1.6:  The Hippo pathway regulates YAP translocation to the 
nucleus.  Phosphorylation of YAP results in retention in the cytoplasm 
and subsequent degradation.  Active state YAP moves to the nucleus to 
act as a co-transcription factor with TEAD1-4 (51). 
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degradation via phosphorylation by the upstream kinases mammalian STE20-like protein kinase 
1 (MST1/2) and large tumor suppressor 1 (LATS1/2), integral members of the Hippo signaling 
pathway (51).  Specifically, Ser112 phosphorylation (Ser127 in humans) by LATS1/2 is 
responsible for cytoplasmic retention, whereas Ser381 mediates recruitment of an E3 ubiquitin 
ligase that targets YAP for degradation (43, 51, 86) (Figure 1.6).  Upon inactivation of Hippo 
signaling or alternative mechanisms for dephosphorylation, YAP translocates to the nucleus 
where it serves as a transcriptional co-activator in association with TEA domain family members 
1-4 (TEAD1-4) and other transcription factors. (51).  Downstream effectors of YAP include 
transcription of genes necessary for cell survival, stabilization and growth, including RUNX, 
SMADs, ankyrins, connective tissue growth factor, amphiregulin, c-myc, and SLC7A5 (27, 34, 
43, 84, 89, 92).   Studies have demonstrated that cell attachment and actin stress fiber formation 
promotes YAP nuclear accumulation, while actin destabilization and detachment leads to 
phosphorylation and cytoplasmic retention via the Hippo pathway (27, 51, 93).  Mechanical 
stimulation can alter Rho GTPase activity and actin cytoskeleton tension in a manner that can 
regulate YAP. Thus, the FAC likely regulates cell growth via actin stabilization and subsequent 
activation of YAP. 
The extent to which YAP can initiate skeletal muscle growth in response to a mechanical 
stimulus remains unclear.  YAP can directly regulate skeletal muscle mass and myofiber size in 
the absence of a mechanical stimulus (34, 86).  In addition, Goodman et al. recently reported 
upregulation of YAP protein expression in response to chronic overload independent of 
mTORC1 activity. AKT (T308) phosphorylation preceded YAP expression and others have 
demonstrated YAP cytoplasmic retention with inhibition of PI3K and PDK1, suggesting that 
YAP activity in response to load may occur via an AKT-dependent signaling pathway (34, 51). 
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The potential for YAP to serve as a positive regulator of muscle mass in response to load is 
strong, yet additional studies are necessary elucidate its role as a primary and/or essential 
mechanosensor.   
The α7β1 integrin 
The α7β1 integrin is highly expressed in skeletal muscle, and is localized primarily at the 
neuromuscular and myotendinous junctions (13).  The α7 subunit preferentially binds laminin in 
the basal lamina of the ECM, and the β1 subunit binds the actin cytoskeleton within the muscle 
fiber, resulting in the stabilization of Z-bands within each sarcomere (3, 11). Absence of the α7 
integrin in muscle provides the basis for a congenital myopathy in humans and elimination in a 
mouse model can result in loss of myofiber and neuromuscular junction integrity, an event 
particularly evident following contraction (10, 11, 13). Endogenous α7β1 integrin mRNA and 
protein are upregulated in skeletal muscle in humans and mice lacking the 
dystroglycan/dystrophin complex in an attempt to compensate for the absence of transmembrane 
adhesion. Interestingly, transgenic overexpression of the α7BX2 integrin can ameliorate the 
pathology and extend the lifespan of mice lacking dystrophin (14). Thus, there is substantial 
evidence to suggest an important role for the α7β1 integrin in the maintenance of myofiber and 
whole muscle structure and function.  
In addition to the structural contribution of the α7β1 integrin to muscle integrity, there is 
evidence to suggest the α7β1 integrin regulates skeletal muscle remodeling in response to a 
mechanical stimulus. Eccentric exercise has been shown to induce upregulation of α7β1 integrin 
mRNA and protein in skeletal muscle of healthy humans and mice (10, 11, 24).  However, the 
literature provides conflicting results as to whether the α7β1 integrin can directly activate 
hypertrophic signaling. In one study, overexpression of the α7BX2 integrin in muscle resulted in 
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suppression of mammalian target of rapamycin (mTOR) and p70S6K activity immediately or 3 
hours following an acute bout of eccentric exercise (10).  In the second study, however, the 
α7BX2 integrin increased mTOR and p70S6K phosphorylation at later time points following 
both acute and multiple (3x/wk for 4 wks) bouts of downhill running (61, 94).  In order to 
understand how the α7β1 integrin can coordinate early changes in transcription post exercise we 
have conducted a microarray analysis 3 hr post downhill running.  We identified alterations of 
many transcripts that may contribute to the α7β1 integrin’s ability to modulate remodeling that 
can promote muscle growth, the results of which are presented in Chapter 2 of this dissertation.  
While both Leuders et al. and Zou et al. show myofiber CSA was increased, no changes in 
muscle weight have been observed (61, 94). This is not entirely unexpected given the aerobic 
nature of the activity. Thus, downhill running, while an excellent model for the assessment of 
muscle repair and the acute response to mechanical stimulation post-exercise, is not an 
appropriate model for evaluation of changes in muscle mass. 
Surgical removal of the gastrocnemius muscle can result in chronic overload of the 
synergist plantaris muscle in mice. Despite the fact that the model is not physiological and can 
result in substantial inflammation, stress, and damage post-surgery, the procedure is relatively 
simple and initiates substantial increases in mTORC1 complex signaling, protein synthesis, 
myofiber CSA and muscle weight within one week (19, 36, 40). The extent to which the α7β1 
integrin heterodimer can serve as a direct upstream regulator of the mTOR signaling pathway 
and/or increased translational efficiency or capacity with chronic loading has not been 
established. Thus, providing a definitive conclusion as to whether the integrin is an intrinsic 
regulator of muscle growth will require incorporation of this in vivo model.  
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We have implemented a modified version of synergist ablation in our lab to address the 
aims outlined in Chapters 3 and 4 of this dissertation. 
Myotenectomy (MTE) requires removal of the 
Achilles tendon, rather than the entire 
gastrocnemius muscle, and the soleus remains intact 
(Figure 1.7). Both modifications allow for equal 
distribution of load across two muscles (plantaris, 
soleus), reducing some of the inflammation and 
damage observed in the plantaris with the classic 
synergist ablation model.  This model still does not perfectly mimic resistance training as 
performed in humans due to chronic induction of mechanical strain.  For our purposes, however, 
we believe this is the best available model for examining structural and functional changes 
modulated by the α7 integrin.  In order to identify early changes in mass and signaling with 
MTE and α7 integrin overexpression, as well as phenotypic and functional changes at a later 
time point, we have compared WT and α7Tg plantaris muscles at 1 day and 14 days post MTE, 
and our findings are presented in Chapter 3 of this dissertation. 
1.5 Aging and Skeletal Muscle Growth 
Sarcopenia describes the loss of muscle mass and eventual loss of function that is 
experienced by the natural aging process. Cadaver studies demonstrate that with aging there is a 
10% decrease in the CSA of the vastus lateralus muscles between age 30-50 and a 25-30% 
increase between ages 50-80.  The CSA of type I fibers are typically maintained while the major 
decrease with aging is seen in the CSA of type II fibers (58). The causes of scaropenia are multi-
faceted, and likely begin with a decrease in anabolic hormones and increased motoneuron death 
Gastro
cnemiu
s-
Plantar
is-
-----Soleus- Gastrocnemius------
Soleus-
Plantaris-
Figure 1.7: Representative diagram of MTE. 
The myotendinous junction of the gastroc 
muscle is removed resulting in chronic 
mechanical loading of the soleus and plantaris. 
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(12, 62).  A loss of the motoneuron means decreased fiber recruitment and activation, which is 
compounded by lifestyle choices typically observed with aging such as decreased activity and 
decreased appetite. Catastrophic injury or illness that results in prolonged bed rest can further 
increase the rate of atrophy.  Increased intramuscular fat infiltration occurs with aging as well, 
which brings an accompanying elevation in macrophages that release proinflammatory cytokines 
such as TNF-α, IL-6, and IL-1.  Chronic inflammation has been associated with decreased 
insulin sensitivity, which further contributes to atrophy of skeletal muscle (38, 69).   Additionally, 
the chronic inflammation in elderly brings with it an increased accumulation of collagen, causing 
fibrosis within the muscle tissue (39).  The resultant phenotype is a muscle with smaller fiber 
cross sectional area that contains increased intramuscular fat and increased fibrosis (58, 68).   
Anabolic resistance refers to an attenuated muscle protein synthetic response to a 
remodeling stimulus such as food ingestion or exercise (22, 25, 31).  Elderly people who 
experience anabolic resistance are unable to increase muscle protein synthesis to a rate that 
sufficiently exceeds degradation, thus attenuating skeletal muscle hypertrophy and further 
contributing to sarcopenia.  Studies have demonstrated this concept through impairment in the 
protein synthetic response to exercise and ingestion of amino acids as demonstrated directly 
through stable isotope tracing studies with accompanying deficits in the activation of 
hypertrophic signaling molecules (22, 25, 31).  The binding partner of the α7 integrin is laminin, 
specifically merosin (laminin-2), however previous literature has also demonstrated binding to 
embryonic isoform laminin-111 (71).  Following our hypothesis that the α7 integrin functions as 
a mechanosensor to activate hypertrophic signaling, we also hypothesize that increased presence 
of fibrosis with age can disrupt α7 integrin-laminin binding and mechanosensing.  The fourth 
and final chapter of this dissertation seeks to address whether this inhibition can be overcome 
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with the overexpression of the α7 integrin in aged mice, while also exploring the alternative 
approach of direct modulation of the ECM through laminin-111 injection. 
1.6 Conclusion 
Researchers have performed groundbreaking studies to identify potential 
mechanotransducers and unravel how resistance exercise contributes to muscle remodeling 
including skeletal muscle hypertrophy. But there is still much that is not known.  The distinct 
mechanisms of mechanotransduction discussed in this literature review, and their varying 
reliance and independence with mTOR demonstrate the complexities of the skeletal muscle 
growth process.  With all that has been discovered, it is clear that there is not just one 
mechanosensor in skeletal muscle, but that synchrony between pathways and sensors work 
harmoniously to achieve optimal increases in protein synthesis and muscle mass.  The purpose of 
this dissertation work is to determine the extent to which the α7β1 integrin can serve as a 
mechanosensor and contribute to the promotion of muscle mass with chronic loading.  
Identifying and understanding all mechanisms that contribute to skeletal muscle 
remodeling are essential for developing strategies to prevent disease- and age-related disabilities.  
Thus, exploring the integrin as an underlying essential regulator of muscle remodeling that may 
lead to increased mass, as well as the underlying basis for sarcopenia, will ultimately provide 
seminal data that will bring us one step closer to achieving this goal.    
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2.1 Abstract  
The α7β1 integrin is concentrated at the costameres of skeletal muscle and provides a critical link 
between the actin cytoskeleton and laminin in the basement membrane. We previously have 
demonstrated that expression of the α7BX2 integrin subunit (MCK:α7BX2) preserves muscle 
integrity and enhances myofiber cross sectional area following eccentric exercise. The purpose 
of this study was to utilize gene expression profiling to reveal potential mechanisms by which 
the α7BX2 integrin contributes to improvements in muscle growth post-exercise. A microarray 
analysis was performed using RNA extracted from skeletal muscle of wild type or transgenic 
mice, under sedentary conditions and 3 hrs following an acute bout of downhill running. Genes 
with FDR p-values below the cutoff of 0.05 (n=73) were found to be regulated by either exercise 
or transgene expression. KEGG pathway analysis detected upregulation of genes involved in ER 
protein processing with integrin overexpression. Targeted analyses verified increased 
transcription of Rpl13a, Nosip, Ang, Scl7a5, Gys1, Ndrg2, Hspa5, and Hsp40 as a result of 
integrin overexpression, alone or in combination with exercise (P<0.05). A significant increase 
in HSPa5 and a decrease in CHOP protein was detected in transgenic muscle (P < 0.05). In vitro 
knockdown experiments verified integrin-mediated regulation of Scl7a5. The results from this 
study suggest that the α7β1 integrin initiates transcription of genes that allow for protection from 
stress, including activation of a beneficial unfolded protein response, and modulation of protein 
synthesis, both which may contribute to positive adaptations in skeletal muscle as a result of 
engagement in eccentric exercise.   
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2.2 Introduction 
Integrins are transmembrane protein heterodimers consisting of α and β subunits.  
Integrins link the cytoskeleton inside the cell with the extracellular matrix outside of the cell, and 
are thus appropriately positioned to facilitate cellular adhesion and migration of a variety of 
mononuclear cells (49).  The integrin can also preserve cellular integrity and transmit 
information in a bidirectional manner across the membrane in multinuclear cells that lack 
capacity for migration, including skeletal muscle.  
The α7β1 integrin is highly expressed in the sarcolemma of skeletal muscle, specifically 
at the Z bands that provide sarcomere stabilization and myofiber integrity during contraction (4, 
6). Loss of the α7β1 integrin results in progressive myopathy that is exacerbated as a result of 
lengthening contractions (10, 11, 6) and provides the basis for a congenital myopathy in humans 
(24). Conversely, overexpression of the α7 integrin subunit (MCK:α7BX2), alone or as a dimer 
with β1, protects against exercise-induced skeletal muscle damage and associated inflammation 
in both wild type mice and mouse models of muscular dystrophy (10, 11, 5, 6, 34, 32).  
We have previously reported that an acute bout of eccentric exercise confers an increase 
in α7 integrin gene expression, including all of the primary isoforms (A/B, X1/X2), at 3 hours 
and a subsequent increase in α7 and/or β1D integrin protein in both mouse (wild type) and 
human skeletal muscle 24 hours post-exercise (6, 14). All studies conducted to date would 
support the conclusion that upregulation of the α7 integrin serves to provide reinforcement and 
protection against mechanical strain associated with contraction. However, the simplistic view of 
the integrin as a structural protein is challenged by prior observations of enhanced satellite cell 
content and myofiber growth in α7 integrin transgenic mice post-eccentric exercise (34, 53).  
Thus, our current work focuses on elucidating novel signaling pathways and patterns of gene 
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expression that may provide a better understanding of mechanisms by which the integrin can 
initiate muscle growth and adaptation post-exercise.     
As a first step in addressing a role for the α7 integrin in the regulation of myofiber 
protection and growth post-exercise, global gene profiling was completed using RNA extracted 
from sex and age-matched WT and α7 integrin transgenic mice (MCK:α7BX2; α7Tg) at 3 hours 
following an acute bout of eccentric exercise.  Results from this study suggest a role for the α7 
integrin in the upregulation of genes related to stress resistance and protein homeostasis.  
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2.3 Materials and Methods 
Animals and downhill running exercise 
All mice were housed in the animal facility at the University of Illinois in a temperature-
controlled specific pathogen-free animal room maintained on a 12:12 light-dark cycle. The 
animals were fed standard laboratory chow and water ad libitum. Protocols for animal use were 
approved by the Institutional Animal Care and Use Committee (IACUC) of the University of 
Illinois at Urbana-Champaign. Mice overexpressing the rat α7 integrin subunit under the control 
of a muscle-specific promoter (MCK:α7BX2; α7Tg) and littermate controls were bred and 
maintained as previously described (5).  
Five week-old WT and α7Tg mice were randomly assigned to a sedentary (SED) or an 
acute exercise (EX) group. Females (n=6/group) and males (n=5-6/group) were equally 
represented in each of the four groups. Acute exercise consisted of a single bout of downhill 
running (−20°, 17 m/min, 40 min) on a treadmill (Exer-6M, Columbus Instruments, Columbus, 
OH). Speed was gradually increased from 10 to 17 m/min over the course of the first 2 min as a 
warm-up and mice were encouraged to run without the use of electrical shock. Mice were 
euthanized via carbon dioxide asphyxiation 3 hr post-exercise. The gastrocnemius-soleus 
complexes were either rapidly dissected and frozen in liquid nitrogen for isolation of RNA, or in 
pre-cooled isopentane for evaluation of tissue sections by microscopy. 
Extraction of RNA 
Frozen gastrocnemius-soleus complexes from both male and female mice were manually 
ground in liquid nitrogen using a mortar and pestle.  Total RNA was extracted from the frozen 
muscle powder in Trizol (TriPure QIAzol, Qiagen, Valencia, CA).  Muscle powder was 
homogenized in Trizol and run through a QiaShredder spin column.  Chloroform was added at 
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room temperature for 2 minutes prior to a 12,000g spin at 4oC for 15 minutes.  The aqueous 
phase was removed and used to extract RNA using Qiagen RNeasy Mini kit according to the 
manufacturer's protocol.  Once extracted, RNA from only the female mice groups were delivered 
to the Roy J. Carver Biotechnology Center at the University of Illinois Urbana-Champaign in 
two aliquots containing 500 ng RNA. One aliquot was used to check quality of the RNA using 
the 2100 Bioanalyzer (Agilent, Santa Clara, CA) and the other aliquot was used for microarray 
analysis. 
Microarray and data analysis 
250 ng of total RNA from each female sample was labeled using the TotalPrep RNA 
Amplification Kit (Ambion, Austin, USA) for cDNA synthesis followed by in vitro transcription 
in order to synthesize biotin-labeled cRNA. 750 ng of biotin-labeled cRNA was hybridized 
overnight to Illumina’s MouseWG-6 v2.0 BeadChips (Illumina, San Diego, USA). Hybridized 
biotinylated cRNA was detected with streptavidin-Cy3 (Amersham Biosciences, USA) and 
scanned with an Illumina iScan reader (Illumina, San Diego, USA). Illumina's MouseWG-6 v2.0 
BeadChip contains 45,281 unique 50-mer probes, which interrogate ~30,800 genes. Each unique 
probe is represented by an average of 43 beads on the array.  Illumina's GenomeStudio 
(V2011.1) Gene Expression Module (V1.9.0) was used to average the individual bead-level 
fluorescence values per probe without background correction or normalization and to compute a 
Detection P-value, which tests whether the bead-level values for each probe were larger than the 
negative control beads. The probe-level expression values and Detection P-value were then 
imported into R (40) (v 3.3.1) for further quality control assessment, normalization and statistical 
analysis using the limma (44) package (v 3.30.0). The arrays were processed with the neqc (43) 
algorithm, which performs a normexp model-based background correction and quantile 
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normalization, then transforms the data to the log2 scale. Microarray files were uploaded to the 
GEO database (accession number GSE79907). 
 Differential gene expression was evaluated by first fitting a mixed-effect 2x2 factorial 
ANOVA model (45) on all 45,281 probes on the array, which adjusted for the correlation of an 
observed batch effect in the data (46). The overall ANOVA F-test, main effects of transgene and 
exercise, the interaction effect and post hoc pairwise comparison between the different 
experimental groups were pulled from the model. Updated mappings from probes to Entrez Gene 
IDs, symbols, gene names and Gene Ontology terms were taken from Bioconductor’s (28) 
illuminaMousev2.db_ 1.26.0 annotation package. Updated mappings to KEGG pathways were 
pulled directly from KEGG on 19 October 2016 using the KEGGREST package (v1.14.0, 12) 
The 50mer probes on the array were designed many years ago based on the mouse 
annotation known at the time. Based on current annotation, some probes no longer interrogate 
any known gene, one probe can interrogate two or more (usually related) genes and more than 
one probe on the array can interrogate the same gene. Additionally, up to 60% of the genes in the 
genome are not expressed in a particular tissue, which can be assessed by the Detection P-value. 
Therefore, the 45,281 probes on the array were collapsed down to 12,971 unique known genes in 
the following sequence: 1) removing probes that did not have at least 3/24 samples with 
Detection P-value < 0.05, 2) removing probes that did not map to any Entrez Gene ID, 3) using 
the lowest Entrez Gene ID for probes that mapped to related genes and 4) selecting a single 
probe with the lowest overall ANOVA P-value for probes that mapped to the same gene.  
Correction for multiple hypothesis testing using the FDR method (2) was done on the raw P-
values for the 12,971 unique genes. Over-representation testing for selected gene sets was done 
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using the GOstats package (18) (v2.40.0) using conditional testing, which removes effects of 
significant child terms before testing parental terms to reduce redundancy. 
Quantitative RT-PCR 
Both female and male samples (total n=10-12/group) were included in follow up qPCR 
and western blotting experiments.  500 ng of unused RNA from the same extraction procedure 
mentioned above were reverse-transcribed into cDNA by High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA).  PCR for specific target genes were 
performed using the 7900HT Fast Real-Time PCR System with Taqman Universal PCR Master 
Mix (Applied Biosystems).  Hypoxanthine phosphoribosyltransferase (Hprt) was used as the 
housekeeping gene and data is expressed as relative to this expression using the ΔΔCT method.  
Female WT SED was used as the reference group.  Taqman primers are reported in Table 1 
(Applied Biosystems). 
In vitro analysis 
Five small hairpin RNAs (shRNAs) in the pLKO.1-puro vector were purchased from 
Sigma-Aldrich (MISSION TRC) for mouse Itg7 and tested to determine efficacy. Clone IDs are: 
(shITGA7 #1, TRCN0000066192; shITGA7 #2, TRCN0000066191; shITGA7 #3, 
TRCN0000442150; shITGA7 #4, TRCN0000066189; shITGA7 #5, TRCN0000066188). A 
shRNA clone with scrambled hairpin sequence (shScramble), a negative control, and lentivirus 
packaging were previously described (20). shITGA7 #4 resulted in a 50% knockdown of α7 
integrin protein compared to scrambled control and was chosen for further analysis. C2C12 
myoblasts were virally transduced and selected in 3 ug/mL puromycin for three days. After 
selection the cells were induced to differentiate into myotubes in the presence of either gelatin 
(collagen) or Matrigel (laminin). RNA (using RLT buffer) and protein (using SDS lysis buffer) 
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were collected from subsets of myotubes formed from a scrambled control transduction, as well 
as shITGA7 #3 and #4 constructs. RNA extraction was performed using Qiagen RNeasy Micro 
kit, and converted to cDNA.  The same method of reverse transcription was used as described 
above. Preamplification steps were performed on genes identified to have transgene main effects 
from the in vivo study.  Gene expression was performed using RT-PCR, and protein expression 
was determined via western blot. 
Evaluation of protein expression 
Powdered tissue was homogenized in ice-cold RIPA buffer containing 50 mM Tris-HCl, 
150 mM NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 1 mM PMSF (in 
100% EtOH), Roche Complete Mini and Roche PhosSTOP. The homogenates were rotated at 
4°C for 1 h and centrifuged at 14,000g for 15 min at 4°C.  The detergent soluble fraction in the 
supernatant was removed and the concentration of protein was determined with the Bradford 
protein assay using bovine serum albumin (BSA) for the standard curve. 
Equal amounts of protein (30 µg) were reduced, separated by SDS-PAGE using 8% 
acrylamide gels, and transferred to nitrocellulose membranes. Equal protein loading was verified 
by Ponceau S staining after transfer and a single prominent band was used to normalize target 
protein. Membranes for detection of α7 were blocked in Tris-buffered saline (pH 7.8) with 
Tween20 (TBST), containing 5% non-fat dry milk (NFDM) overnight, followed by a primary 
incubation in purified α7 CDB 347 polyclonal rabbit anti-rat antibody (1:1000) for 1 h. 
Membranes for p-IRE1α (Ser724), CHOP and BiP were blocked for 1hr in 5% NFDM in TBST, 
while p-eIF2α (Ser51) was blocked in 5% BSA. Primary antibody (1:1000) was applied in 5% 
NFDM overnight.  The following antibodies were used: α7 integrin CDB polyclonal rabbit anti-
rat antibody, CHOP (L63F7) (Cell Signaling, 2895S), GRP78/HSPa5/BiP (Enzo Life Sciences, 
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ADI-SPA-826-D), IRE1α (Ser724) (Novus Biologicals, NB100-2323), eIF2α (Ser51) (119A11) 
(Cell Signaling, 3597S), and SLC7A5 (Bioss Antibodies, bs-10125R).  Horseradish peroxidase-
conjugated anti-rabbit secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, 
PA) was applied for 1 h at 1:20,000 for α7 integrin, and 1:3000 for the other four proteins. Bands 
were detected using SuperSignal West Dura Extended Duration Substrate (Thermo Scientific, 
Rockford, IL) and a Bio-Rad ChemiDoc XRS system (Bio-Rad, Hercules, CA). Quantification 
was completed using Quantity One software (Bio-Rad). 
Statistical analysis 
Analysis of the array data was completed as described above. For all other experiments, 
averaged data are presented as the mean ± SEM. Two-way ANOVA was completed to determine 
if an interaction or main effects were present as a result of transgene expression, sex and exercise 
(SPSS, version 16). T-tests were completed to determine if gene expression was significantly 
different between scramble and knockdown. Data was considered significant at P < 0.05. 
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2.4 Results 
Verification of transgene expression and clustering analysis 
 The mouse-specific 50mer probe for α7β1 integrin on the microarray has enough 
sequence divergence to prevent hybridization of rat α7β1 integrin RNA. Thus, both mouse and 
rat α7β1 integrin RNA and protein were evaluated using qPCR and western blotting methods. 
Total α7β1 protein was increased approximately 4-fold in both male and female α7Tg mouse 
muscle compared to wild type controls (transgene main effect, P < 0.05) (male and female data 
collapsed, data not shown).  Rat α7 integrin gene expression was higher in male transgenic mice 
compared to female (sex x transgene interaction, P < 0.05) (Figure 2.1A). Endogenous mouse α7 
integrin gene expression was elevated in both male and female transgenic mice compared to WT 
(2-fold, transgene main effect, P < 0.05), and total amount was higher in males than females 
independent of transgene expression (sex main effect, P < 0.05) (Figure 2.1B). Exercise did not 
increase endogenous mouse integrin expression at this early time point. 
The overall ANOVA F-test detected only 73 genes with FDR P-values below the 
traditional cutoff of 0.05 (Table 2). However, when gene expression changes are not widespread 
it can be difficult to find any with very low FDR P-values because of the sheer number of genes 
tested. To gain a better understanding of the overall patterns of expression changes due to 
transgene and exercise effects, we created a heatmap of 274 genes that had overall ANOVA raw 
P-values < 0.005, which was equivalent to an FDR rate of 0.24 (Figure 2.1C). Four main clusters 
of genes were evident, splitting into groups of those generally affected by the transgene only 
(black and purple clusters, 57 and 92 genes respectively) and those generally affected by exercise 
only (green and yellow clusters, 72 and 53 genes respectively) although the effect appears 
stronger in α7Tg mice compared to WT. Over-representation testing for KEGG pathways was 
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completed separately for each of the four gene clusters. The purple cluster, which had higher 
expression due to the transgene, had over-representation of genes in the protein processing in the 
endoplasmic reticulum (ER) pathway (Sec61g, Xbp1, Map2k7, Herpud1, Ssr3, Syvn1). The 
green cluster, which had higher expression due to exercise, had over-representation of genes in 
the estrogen signaling pathway (Adcy4, Fkbp5, Hspa8, Hsp90a1, Hspa1a, Hsp90b1), mineral 
absorption pathway (Atp1a1, Mt1, Mt2), insulin resistance pathway (Socs3, Ppargc1a, Stat3, 
Ppp1r3c), and thyroid hormone synthesis pathway (Adcy4, Atp1a1, Hsp90b1). Neither the 
yellow or black clusters had any pathways over-represented at raw P < 0.005. 
We further assessed the pairwise responses for the 274 genes by using the same raw P-
value cutoff of 0.005 to compare the response to exercise in WT vs. α7Tg mice (Figure 2.1D) 
and the effect of the transgene in sedentary vs. exercised mice (Figure 2.1E). Consistent with the 
visual interpretation of the heatmap, transcription was altered to a greater extent in response to 
exercise in α7Tg muscle (87 genes) compared to WT (24 genes), although of these only 12 and 6 
genes respectively reached the raw P < 0.005 threshold for the interaction effect (interpreted here 
to be the difference in response to exercise). Only 8 genes showed a similar response to exercise 
at this threshold. The transgene effect was more similar under sedentary and exercised conditions, 
with 52 genes shared between them. Of the 63 genes with raw P < 0.005 only under sedentary 
condition, only 11 reached the same threshold for the interaction effect (interpreted here to be the 
difference in transgene effect) and likewise of the 52 genes only under exercised condition, only 
5 reached the threshold for the interaction effect.  
Targeted verification by qPCR was completed on genes previously documented to 
regulate muscle growth or protection from damage, the majority listed in Table 2 (most 
responsive to exercise or transgene expression).  
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Effect of acute eccentric exercise on skeletal muscle gene expression 
Several genes were responsive to the acute bout of eccentric exercise in both WT and 
α7Tg muscle and were verified by qPCR, including metallothioneins 1 (Mt1) and 2 (Mt2) (3.5 to 
4-fold, exercise main effect, P < 0.05) (Figures 2.2A-B), peroxisome proliferator-activated 
receptor-γ coactivator (PGC)-1α (Ppargc1a) (3-fold, exercise main effect, P < 0.05) (Figure 
2.2C), and muscle-specific kinase (Musk) (2-fold, exercise main effect, P < 0.05) (Figure 2.2D). 
Although not included in our list of the top 73 genes, heat shock protein 90b1 (Hsp90b1) (1.5 to 
2-fold, exercise main effect, P < 0.05) (Figure 2.2E) and Hspa1a (a member of the Hsp70 family) 
(3 to 4-fold, exercise main effect, P < 0.05) (Figure 2.2F) were also detected in the array and 
verified.   
Effect of α7 integrin overexpression on skeletal muscle gene expression  
Several genes regulated by transgene expression were selected for verification by qPCR, 
including ribosomal protein L13a (Rpl13a) (20%, transgene main effect, P < 0.05) and nitric 
oxide synthase interacting protein (Nosip) (2-fold, transgene main effect, P < 0.05) (Figure 2.3 
A-B).  Gene expression of angiogenin (Ang) and solute-linked carrier 7A5 (Slc7a5), both 
regulators of protein translation, was increased as a result of integrin overexpression, and this 
effect was augmented by exercise (1.5 to 2.5-fold, transgene and exercise main effects, P<0.05) 
(Figures 2.3C-D). Conversely, glycogen synthase (Gys1) and n-myc downstream-regulated gene 
2 (Ndrg2) gene expression was increased in α7Tg mice, yet this effect was attenuated as a result 
of exercise (transgene x exercise interaction, P < 0.05) (Figures 2.3E-F).  The microarray results 
indicated that branched chain amino acid transaminase 2 (Bcat2) was elevated in both basal and 
exercise transgenic groups over wild type (Table 2), but qPCR did not validate this finding.  Due 
to impact of the integrin on genes related to protein translation, we evaluated 18s and 28s 
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ribosomal RNA (rRNA) (normalized to total RNA using data provided by the Agilent 
Bioanalyzer). No significant differences in rRNA content were detected between WT and α7Tg 
mice, in the absence or presence of acute exercise. 
Hsp40 (Dnajb9) was increased in α7Tg mice and preferentially expressed in males 
(transgene and sex main effects, P < 0.05) (Figures 2.4A-B). Due to the results from KEGG 
analysis and the fact that chaperone protein-related gene expression has been reported to be 
elevated in α7Tg mice in other microarrays  (32), we also evaluated expression of heat shock 
70kDa protein 5 (Hspa5), also known as immunoglobulin binding protein (BiP) and 78 kDa 
glucose-regulated protein (Grp78), and activating transcription factor 6 (Atf6). Hspa5 was 
significantly increased in α7Tg mice and preferentially expressed in males and in response to 
exercise (transgene, exercise and sex main effects, P < 0.05) (Figures 2.4C-D).  Atf6 was 
significantly increased in male transgenic mice and in response to exercise (transgene, exercise 
and sex main effects, P<0.05) (Figure 2.4F), but not altered in females, resulting in no apparent 
effect when males and female groups were combined (Figure 2.4E). 
 Due to the complex role of BiP in the regulation of protein folding and coordination of 
the unfolded protein response (UPR), BiP protein expression and UPR associated protein 
activation were assessed in both male and female mice (representative blots shown in Figure 
2.5A).  BiP protein was significantly increased in α7Tg mice, independent of exercise and sex 
(60%, transgene main effect, P < 0.05) (Figure 2.5B).  Significant alterations in UPR-mediated 
signaling, including inositol-requiring enzyme 1 α (IRE-1α) and eukaryotic initiation factor 2 α 
(eIF2α) phosphorylation, were not detected at 3 hr post-eccentric exercise in WT or α7Tg mice 
(Figures 2.5C-D), but downstream mediator of stress induced apoptosis CAAT-enhancer-binding 
protein homologous protein (CHOP) was significantly reduced in in α7Tg mice (20%, transgene 
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main effect, P < 0.05) (Figure 2.5E) (52). No differences in UPR-mediated signaling were 
detected between males and females. 
Knockdown of the α7 integrin regulates Slc7a5 transcription 
 We validated two constructs that could effectively knockdown α7 integrin protein 
expression in C2C12 myotubes (shITGA7 #3 and #4) compared to a scramble control (Figure 
2.6A). While Slc7a5 and Ndrg2 transcription was significantly decreased with α7 integrin 
knockdown, several genes were not consistently altered, including Rpl13a, Nosip, Gys1, Hsp40, 
Hspa5/BiP, and Atf6 (Figure 2.6C). Ang gene expression increased with α7 integrin knockdown. 
The experiment was repeated using Matrigel (laminin) as a substrate to ensure proper integrin 
linkage in the scramble control (Figure 2.6D). Slc7a5 expression remained decreased, but Ang 
was no longer significant and Ndrg2 was increased in response to knockdown. Given the 
consistent change in Slc7a5 transcription, we evaluated SLC7A5 protein expression in the 
muscle of WT and α7Tg mice. We found that protein expression was increased in α7Tg 
compared to WT (transgene and exercise main effects, P < 0.05) (Figure 2.6B). 
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2.5 Discussion 
 We have previously established that α7β1 integrin mRNA and protein are significantly 
enhanced in mouse and human skeletal muscle in response to an acute bout of eccentric exercise 
(6). The integrin protein is localized to the sarcolemma, particularly at the costamere and 
myotendinous junction, suggesting this structure provides stabilization and protection from 
damage in response to strain associated with eccentric lengthening. Indeed, transgenic mice 
created to overexpress the α7BX2 integrin subunit in skeletal muscle display protection from 
damage and inflammation post-exercise. Coincident with enhanced integrity is a phenotype of 
increased satellite cell quantity, new fiber synthesis and increased myofiber cross sectional area 
following single or repeated bouts of eccentric exercise (34, 53).  The purpose of this study was 
to investigate global gene transcription of skeletal muscle in this unique animal model to reveal 
potential mechanisms by which the α7β1 integrin can facilitate the positive benefits of eccentric 
exercise.  The results suggest an important role for the integrin in upregulation of genes that 
confer resistance to stress and modulation of protein translation.  
 The downhill running model used for this experiment increased the expression of several 
genes, including Mt1, Mt2, Ppargc1α, Musk, Hsp90b1, and Hspa1a (Hsp70), which when 
analyzed together suggest that this exercise paradigm was sufficiently stressful to elicit an early 
adaptive response in both WT and α7Tg mice. The precise function of the metallothioneins are 
not fully understood, but they are believed to possess physiological metal (zinc and copper) 
binding capacity and serve as antioxidants (41, 42, 22, 1).  In concert with PGC-1α, an essential 
regulator of mitochondrial biogenesis, both are likely enhanced in skeletal muscle to provide 
protection against oxidative stress associated with increased metabolism during exercise. In 
addition to metabolic stress, lengthening during eccentric exercise can damage the sarcolemma 
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and muscle ultrastructure. The upregulation of muscle-specific kinase (Musk), a necessary 
component of the neuromuscular junction (21, 9), as well as important heat shock proteins, may 
be necessary to stabilize the myofiber and ensure proper innervation and protein folding 
immediately following exercise. The fact that Mt1, Mt2, and PGC-1α gene expression is equally 
enhanced in both WT and α7Tg muscle suggest that the integrin may not be an essential 
regulator of protection from oxidative stress post-exercise.  
 Overall, relatively few transcripts were altered with overexpression of the α7β1 integrin 
in skeletal muscle in the present array (73 genes), a finding similar to a previous report (32). 
Despite the lack of global change in gene expression, the α7β1 integrin appears to increase 
expression of key genes related to stress resistance, protein translation, and amino acid transport 
in a manner that is either unaltered by exercise (Rpl13a, Nosip, Hsp40,), further enhanced by 
exercise (Ang, Slc7a5), or suppressed by exercise (Gys1, Ndrg2). Under conditions of nutrient 
stress and hypoxia, RPL13a can increase translation of mRNAs with an internal ribosome entry 
site (IRES), and this cap-independent mechanism is used to translate proteins such as molecular 
chaperones, growth factors, and anti-inflammatory cytokines necessary for cellular survival (35, 
26, 30, 47, 31). Microarray results for Rpl13a demonstrate an elevation over a thousand-fold in 
α7Tg muscle as compared to WT regardless of exercise. The increase was much less dramatic 
upon verification with qPCR, yet still significant. Angiogenin can similarly increase cap-
independent translation during times of stress, as well as serve as a transcription factor for 
ribosomal RNA (rRNA) during periods of growth post-stress (51, 17, 29, 38). Interestingly, Ang 
was substantially increased as a result of both integrin overexpression and exercise in α7Tg 
muscle.  Finally, transcription of the LAT1 amino acid transport protein, SLC7A5, also was 
increased in response to integrin overexpression and exercise, an event that may contribute to 
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increased muscle protein synthesis post-exercise (15). Minimal information exists regarding 
NOSIP and NDRG2 in skeletal muscle, yet studies suggest localization at the cell membrane and 
regulation of nitric oxide and mTORC1 signaling, respectively (13, 16, 8, 19). Taken together, 
the results from this study suggest a predominant role for the α7β1 integrin in the modulation of 
protein translation in a manner that may provide protection from stress and increased growth 
following eccentric exercise.   
HSP40 (DnaJ) stimulates ATPase activity of HSP70, and thus regulates the function of 
this important chaperone protein (36, 39). Hsp40 gene expression was significantly increased in 
α7Tg muscle pre- and post-exercise. Results from KEGG analysis and previous array data (32) 
suggested regulation of protein processing in the ER.  Thus, we examined two other transcripts 
related to the UPR, including Hspa5 (BiP) and Atf6.  BiP is located in the lumen of the 
endoplasmic reticulum (ER) and serves as an important molecular chaperone that can fold and 
assemble newly synthesized protein. Accumulation of unfolded proteins in the ER stimulates the 
release of BiP from transmembrane receptor proteins and initiates several events that serve to 
ensure cellular integrity during short periods of growth or stress (adaptive UPR); or serve to 
commit the cell to apoptosis during prolonged stress (maladaptive UPR).  BiP expression was 
increased in α7Tg muscle in the rested state and post-exercise, a result that was more evident in 
males. Atf6 expression was also significantly increased in both WT and α7Tg males compared to 
females and further enhancement was detected with integrin overexpression and exercise. 
Results from Wu et al. (50) demonstrate that PGC-1α serves as a coactivator with ATF6 to 
enhance BiP expression in vitro. Our data suggest this mechanism may allow for increased BiP 
mRNA and protein in male mice post-exercise. However, the lack of PGC-1α mRNA in the 
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rested state (Figure 2.2C) suggests an alternative coactivator may be necessary to account for the 
enhancement in BiP during rest conditions.  
Intracellular signaling pathways in the ER provide the mechanistic basis for UPR 
following the initiation of stress, including 1) protein kinase RNA-like endoplasmic reticulum 
kinase (PERK) autophosphorylation and subsequent phosphorylation of the α subunit of eIF2 
(resulting in attenuation of protein translation), 2) inositol-requiring enzyme 1 α (IRE-1α) 
phosphorylation and subsequent cleavage and translocation of the transcription factor XBP1 
(resulting in upregulation of chaperone proteins and elements necessary for protein degradation), 
and 3) ATF6 cleavage and translocation to the nucleus (resulting in upregulation of chaperone 
proteins) (25, 27). In the current study, trends for an increase in IRE-1α phosphorylation and a 
decrease in eIF2α phosphorylation were detected in α7Tg muscle at 3 hours post-exercise, 
suggesting some ability for the integrin to regulate UPR in the context of exercise. These 
changes may account for the UPR observed following acute resistance exercise in humans (37). 
Despite the fact that UPR signaling was not highly regulated with transgene expression or 
exercise, CHOP protein expression was significantly attenuated in α7Tg muscle independent of 
exercise. This observation is in disagreement with results from Liu et al. (32) that report an 
increase in Chop mRNA in α7Tg muscle. However, the results are in agreement with studies that 
report the ability for the α7 integrin to protect against apoptosis (32), both in myoblasts in culture 
as well as in the muscle fiber of mice with muscular dystrophy (7). The fact that a maladaptive 
UPR is present during rapid growth associated with chronic loading suggests that UPR may not 
provide the mechanistic basis for α7 integrin-mediated growth following eccentric exercise (23). 
However, further studies are necessary to address this important question. The extent to which 
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the integrin can accelerate or further enhance growth observed in response to chronic loading has 
not been evaluated and is the focus of our current work. 
We evaluated the ability for the α7 integrin to directly regulate transcription using an in 
vitro knockdown approach.  We incorporated two different substrates, including gelatin 
(collagen) and Matrigel (laminin), to account for the influence of integrin activation on gene 
transcription in the scrambled controls.  Slc7a5 gene transcription was significantly decreased 
with α7 integrin knockdown, regardless of substrate. However, this was the only gene out of nine 
tested that was consistently altered in vitro. We have previously documented that myogenic and 
perivascular stem cells are enhanced in α7 integrin transgenic muscle under sedentary conditions 
and post-exercise (34, 48). Thus, we speculate that the gene signature reported in this study may 
be influenced by an alteration in mononuclear cell composition.  In vitro assessment will be 
necessary to directly link sarcolemmal integrin with transcriptional control in the absence and/or 
presence of mechanical cues.  Regardless, it is clear from this study that the α7 integrin can 
directly and rapidly control Slc7a5 transcription, and enhancement of this vital amino acid 
transporter in muscle may significantly contribute to initiation of growth post-exercise.  
 The results from this study provide seminal information regarding the molecular basis by 
which the α7β1 integrin may facilitate protection from damage as well as promote myofiber 
growth following eccentric exercise. Future work will strive to elucidate a role for an adaptive 
UPR and SLC7A5 transcription in the promotion of growth post-exercise, as well investigate the 
impact of aging on integrin protein expression, activation and signaling. This information will be 
essential for improving our current understanding of anabolic resistance and creating new 
paradigms that can help preserve muscle mass and function across the lifespan.       
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2.9 Figure Legends & Figures 
Figure 2.1 
 
Figure 2.1. Verification of transgene expression and impact of the α7 integrin on gene 
clustering after acute downhill running.  Sex differences were evident in rat (A) and mouse 
(B) α7β1 integrin gene expression. Heat map of 274 genes with the most evidence for change 
within female groups (C).  Red represents upregulation and blue represents downregulation. The 
four clusters are identified by color, including upregulation by the transgene (purple), 
downregulation by the transgene (black), upregulation by exercise (green) and downregulation 
by exercise (yellow).  Venn diagrams representing differential response to exercise (D) and 
overexpression of the α7 integrin subunit (E) in female WT and α7Tg skeletal muscle.  *Indicates 
a transgene main effect (P ≤ 0.05).  †Indicates a sex main effect (P ≤ 0.05). All values are mean 
± SEM, and all genes are normalized to Hprt.  Data are expressed relative to WT-SED Female. 
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Figure 2.2 
 
Figure 2.2. Acute eccentric exercise increases gene expression in skeletal muscle 
independent of the transgene.  Mt1, Mt2, Ppargc1α, Musk, Hsp90b1, and Hspa1a gene 
expression was examined in skeletal muscle (A-F). ‡Indicates an exercise main effect (P ≤ 0.05). 
All values are mean ± SEM, and all genes are normalized to Hprt and are expressed relative to 
WT-SED.  
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Figure 2.3 
 
Figure 2.3. The α7 integrin regulates skeletal muscle gene expression.  Rpl13a, Nosip, Ang, 
Slc7a5, Gys1, and Ndrg2 gene expression was examined in skeletal muscle (A-F). *Indicates a 
transgene main effect (P ≤ 0.05). ‡Indicates an exercise main effect (P ≤ 0.05). All values are 
mean ± SEM, and all genes are normalized to Hprt and are expressed relative to WT-SED.  
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Figure 2.4 
 
Figure 2.4. The α7 Integrin augments expression of genes necessary for protection from 
stress.  Gene expression of Hsp40 (Dnajb9), Hspa5, and Atf6 combined (A, C, E) and by sex (B, 
D, F) was examined in skeletal muscle. *Indicates a transgene main effect (P ≤ 0.05). ‡Indicates 
an exercise main effect (P ≤ 0.05).  †Indicates a sex main effect (P ≤ 0.05).  All values are mean 
± SEM and all genes are normalized to Hprt.  Combined data are expressed relative to WT-SED 
and sex differences are expressed relative to WT-SED Female. 
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Figure 2.5 
 
Figure 2.5. The α7 integrin stimulates a beneficial UPR in skeletal muscle.   Representative 
immunoblots of UPR-associated proteins (A). Summary of data for total BiP (HSPa5) (B), 
phospho-IRE-1α (C), phospho-eIF2α (D), and total CHOP (E). *Indicates a transgene main effect 
(P ≤ 0.05). All values are mean ± SEM and all proteins are normalized to Ponceau S and are 
expressed relative to WT-SED. M=male, F=female. 
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Figure 2.6 
 
Figure 2.6. In vitro evaluation of α7 integrin-mediated gene transcription.  Validation of two 
constructs that allow for α7 integrin knockdown in myotubes (A). SLC7A5 protein expression 
was examined in skeletal muscle (B). Evaluation of target gene transcription with α7 integrin 
knockdown (B-C). *Indicates a transgene main effect (P ≤ 0.05). ‡Indicates an exercise main 
effect (P ≤ 0.05). *Indicates different from scramble control (P ≤ 0.05). All values are mean ± 
SEM, and all genes are normalized to Hprt and are expressed relative to scramble control.  
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  Table 2.1: List of Taqman gene expression assays 
  Gene Name / Symbol Assay ID 
1 Activating transcription factor 6 (ATF6) Mm01295319_m1 
2 Angiogenin, ribonuclease, RNase A family, 5 (ANG) Mm00833184_s1 
3 DnaJ [Hsp40] homolog, subfamily B, member 9 (Dnajb) Mm01622956_s1 
4 Glycogen synthase 1, muscle (GYS1) Mm01962575_s1  
5 Heat shock protein [HSP72] 1A (HSPa1a) Mm01159846_s1  
6 Heat shock protein [Grp78/BiP] 5 (HSPa5) Mm00517691_m1 
7 Heat shock protein 90, beta [Grp94], member 1 (HSP90b1) Mm00441926_m1 
8 Hypoxanthine guanine phosphoribosyl transferase (Hprt) Mm01545399_m1 
9 Integrin alpha 7 (Itga7) Mouse Mm00434400_m1 
10 Integrin alpha 7 (Itga7) Rat Rn01529354_m1 
11 Metallothionein 1 (Mt1) Mm00496660_g1 
12 Metallothionein 1 (Mt2) Mm00809556_s1 
13 Muscle, skeletal, receptor tyrosine kinase (MuSK) Mm01346929_m1 
14 Nitric oxide synthase interacting protein (NOSIP) Mm00481528_m1 
15 N-myc downstream regulated gene 2 (NDRG2) Mm00443481_g1 
16 Peroxisome proliferative activated receptor, gamma, coactivator 1 alpha (Ppargc1a) Mm01208835_m1 
17 Ribosomal protein L13A (RPL13a) Mm01612986_gH 
18 Solute carrier family 7 [cationic amino acid transporter, y+ system], member 5 (SLC7A) Mm00441516_m1 
 
Table 2.2: The top 73 responsive genes (ANOVA FDR P< 0.05) 
PROBEID ENTREZID SYMBOL ANOVA.fdrP Main Effect fdrPval Direction 
ILMN_1251254 14936 Gys1 3.48E-14 Transgene 1.62E-15 Up 
ILMN_1219510 22121 Rpl13a 2.73E-13 Transgene 1.21E-14 Up 
ILMN_2783557 233189 Ctu1 2.84E-06 Transgene 1.63E-07 Down 
ILMN_2890743 66394 Nosip 1.11E-05 Transgene 6.51E-07 Up 
ILMN_2794608 12036 Bcat2 2.82E-05 Transgene 1.99E-06 Up 
ILMN_2740006 246694 Hps5 4.29E-05 Transgene 2.36E-06 Down 
ILMN_1230327 14325 Ftl1 4.61E-05 Transgene 2.55E-06 Up 
ILMN_2596522 17748 Mt1 0.000125 Exercise 6.74E-05 Up 
ILMN_2619156 16495 Kcna7 0.000125 Transgene 9.86E-06 Down 
ILMN_2815889 101612 Grwd1 0.000196 Transgene 1.18E-05 Up 
ILMN_2501719 72088 Ush1c 0.000249 Transgene 1.52E-05 Up 
ILMN_2971314 71755 Dhdh 0.000249 Transgene 1.52E-05 Down 
ILMN_2603834 53415 Htatip2 0.000324 Transgene 1.95E-05 Down 
ILMN_2667101 67023 Use1 0.000355 Transgene 2.78E-05 Up 
ILMN_1217519 71960 Myh14 0.000355 Transgene 3.90E-05 Down 
ILMN_3102085 69217 Plekha4 0.000365 Transgene 3.48E-05 Down 
ILMN_1215969 217864 Rcor1 0.000701 Transgene 7.78E-05 Down 
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LMN_3135697 66869 Zfp869 0.00075 Transgene 5.98E-05 Up 
ILMN_2875251 11727 Ang 0.00125 Transgene 0.000254 Up 
ILMN_1221081 211135 D130040H23Rik 0.002 Transgene 0.000421 Up 
ILMN_2485340 269181 Mgat4a 0.00421 Transgene 0.000447 Down 
ILMN_3160146 626359 Wdr93 0.00558 Transgene 0.0129 Up 
ILMN_1219154 17750 Mt2 0.00558 Exercise 0.00399 Up 
ILMN_2912111 234358 Zfp930 0.006 Transgene 0.000453 Up 
ILMN_1236577 72368 Borcs8 0.006 Transgene 0.000487 Down 
ILMN_2598576 11546 Parp2 0.00618 Transgene 0.000613 Up 
ILMN_2768053 77945 Rpgrip1 0.00709 Transgene 0.00119 Up 
ILMN_2918402 102247 Gpat4 0.00722 Transgene* 0.0863 Up 
ILMN_2667463 77090 Ocel1 0.00979 Transgene 0.00121 Down 
ILMN_1249498 56193 Plek 0.0104 Transgene 0.00155 Up 
ILMN_2710139 19017 Ppargc1a 0.0109 Exercise 0.014 Up 
ILMN_2711948 20539 Slc7a5 0.0117 Exercise 0.014 Up 
ILMN_1255422 12457 Noct 0.0131 Exercise 0.014 Up 
ILMN_2662648 225115 Svil 0.0139 Exercise* 0.158 Up 
ILMN_3002505 64296 Abhd8 0.0139 Transgene 0.00155 Down 
ILMN_1239578 17158 Man2a1 0.0139 Exercise 0.0168 Up 
ILMN_1224768 98878 Ehd4 0.0139 Exercise* 0.0509 Up 
ILMN_2846255 66522 Pgpep1 0.0139 Transgene 0.0015 Up 
ILMN_2550291 66923 Pbrm1 0.0141 Transgene 0.00412 Down 
ILMN_1252338 545123 Cyp2d11 0.0146 Transgene 0.0015 Up 
ILMN_1217966 384775 1700003H04Rik 0.0205 Transgene 0.00412 Up 
ILMN_2813487 18626 Per1 0.0209 Transgene 0.0339 Up 
ILMN_2709864 226043 Cbwd1 0.0215 Transgene 0.012 Up 
ILMN_1254516 18203 Ntan1 0.0262 Transgene 0.00591 Down 
ILMN_1245437 68188 Sympk 0.0273 Transgene 0.00412 Up 
ILMN_2773395 12845 Comp 0.0275 Transgene 0.00305 Down 
ILMN_2668886 218989 Tmem260 0.0294 Transgene 0.0108 Up 
ILMN_2900827 76900 Ssbp4 0.0315 Transgene 0.00418 Down 
ILMN_2829636 27362 Dnajb9 0.0331 Transgene 0.00711 Up 
ILMN_3102277 18198 Musk 0.0339 Exercise 0.0291 Up 
ILMN_1259294 68472 Tmem126b 0.0339 Exercise* 0.104 Up 
ILMN_2597332 58248 1700123O20Rik 0.0339 Transgene 0.00498 Up 
ILMN_2595732 18030 Nfil3 0.0339 Exercise* 0.0766 Up 
ILMN_2697552 18578 Pde4b 0.0353 Exercise* 0.126 Up 
ILMN_2972585 52118 Pvr 0.0381 Transgene 0.00711 Up 
ILMN_2631903 69301 Tescl 0.0382 Transgene 0.00711 Down 
ILMN_2903511 50783 Lsm4 0.0382 Transgene 0.0108 Down 
ILMN_2771991 29811 Ndrg2 0.0382 Transgene 0.00711 Up 
ILMN_2769734 59045 Stard3 0.0387 Transgene 0.0263 Up 
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ILMN_1249654 53609 Clasrp 0.0411 Transgene 0.00711 Up 
ILMN_1217308 16618 Klk1b26 0.044 Transgene 0.0073 Down 
ILMN_2667091 53412 Ppp1r3c 0.044 Transgene* 0.11 Up 
ILMN_2516383 107513 Ssr1 0.0441 Transgene 0.00711 Down 
ILMN_2696270 59047 Pnkp 0.0456 Transgene 0.00711 Down 
ILMN_1259368 80287 Apobec3 0.0456 Exercise* 0.0942 Up 
ILMN_2476881 72899 Macrod2 0.046 Transgene 0.00711 Down 
ILMN_1232067 234388 Ccdc124 0.0469 Transgene 0.00655 Up 
ILMN_1245263 77106 Tmem181a 0.0471 Transgene 0.00711 Up 
ILMN_2907972 72297 B3gnt3 0.0471 Transgene 0.00891 Up 
ILMN_2495289 110172 Slc35b1 0.0471 Transgene 0.00711 Up 
ILMN_2741070 259026 Olfr378 0.0471 Transgene 0.0124 Up 
ILMN_1242427 104099 Itga9 0.0481 Exercise* 0.0509 Up 
ILMN_2811918 243963 Zfp473 0.0481 Transgene 0.00875 Up 
*Indicates main effect fdrPval > 0.05 
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3.1 Abstract 
The α7β1 integrin is a transmembrane adhesion protein localized to the costameres of skeletal 
muscle, providing a critical link between the actin cytoskeleton and laminin in the basement 
membrane. The purpose of this study was to determine the extent to which the α7BX2 integrin 
contributes to myofiber hypertrophy following chronic overload. Myotenectomy (MTE) of the 
gastrocnemius muscles was performed on 6 mo, male wild type (WT) and MCK:α7BX2 (α7Tg) 
mice. Muscle growth and hypertrophic signaling was examined at 1 (1D) and 14 days (14D) 
post-MTE. Wet muscle weight was increased in both WT and α7Tg, yet significantly higher in 
α7Tg at 1D and 14D post-MTE (26% WT vs. 58% α7Tg at 1D; 38% WT vs. 68% α7Tg at 14D 
compared to sham). The percentage of large caliber fibers (>2,000 µm) and the total number of 
fibers was increased in α7Tg compared to sham at 1D and 14D post-MTE, respectively. MTE 
initiated a stress and myofiber repair response (p38 phosphorylation, % CLN+ fibers) in WT that 
was not observed in α7Tg. Despite augmentation of growth in α7Tg compared to WT, mTOR 
and p70S6K phosphorylation was either partially or fully suppressed in α7Tg at 1D post-MTE. 
4E-BP1(Ser65) phosphorylation was increased 1D post-MTE and an elevation in baseline YAP 
protein expression was observed in α7Tg muscle. The results from this study suggest that the 
α7β1 integrin augments the growth response to chronic loading and mTOR-independent events 
may contribute to this observation.   
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3.2 Introduction 
Integrins are transmembrane adhesion proteins that serve to link the actin cytoskeletal 
inside a cell with the external microenvironment. Upon binding to the preferential ligand within 
the extracellular matrix (ECM), the integrin will undergo a conformational change in a manner 
that allows for the association of several proteins, including vinculin, α-actinin, talin, integrin 
linked kinase (ILK) and focal adhesion kinase (FAK). Together, the integrin and its associated 
proteins develop the focal adhesion complex (FAC). One important role of the FAC is to 
transmit force produced by contraction outward to the ECM, as well as transmit force associated 
with strain from the outside in.  
The α7β1 integrin heterodimer is highly expressed in skeletal muscle, and is localized 
primarily at the neuromuscular and myotendinous junctions (6).  The α7 subunit preferentially 
binds laminin in the basal lamina of the ECM, and the β1 subunit binds the actin cytoskeleton 
within the muscle fiber, resulting in the stabilization of Z-bands within each sarcomere (1, 5). 
Absence of the α7 integrin in muscle provides the basis for a congential myopathy in humans 
and elimination in a mouse model can result in loss of myofiber and neuromuscular junction 
integrity, an event particularly evident following contraction (5, 6). Endogenous α7β1 integrin 
mRNA and protein are upregulated in skeletal muscle in humans and mice lacking the 
dystroglycan/dystrophin complex in an attempt to compensate for the absence of transmembrane 
adhesion. Interestingly, transgenic overexpression of the α7BX2 integrin can ameliorate the 
pathology and extend the lifespan of mice lacking dystrophin (7).   
α7β1 integrin mRNA and protein are also upregulated in skeletal muscle of healthy 
humans and mice following exercise (3, 5, 13, 31). Overexpression of the α7 integrin in healthy 
mice (MCK:α7BX2; α7Tg) can protect skeletal muscle from eccentric exercise-induced damage 
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and force deficits associated with downhill running (3, 5, 38).  Despite protection from damage, 
a paradoxical and robust increase in satellite cell accumulation and new fiber synthesis is 
observed in α7Tg muscle post-exercise (38). Thus, there is substantial evidence to support an 
important role for the α7β1 integrin in the maintenance of myofiber and whole muscle structure 
and function in response to eccentric exercise.  
In addition to the protective contribution of the α7β1 integrin, there is evidence to suggest 
the α7β1 integrin can initiate hypertrophic signaling and growth in response to a mechanical 
stimulus. Currently the literature provides conflicting results as to whether the α7β1 integrin can 
activate the mammalian target of rapacmycin complex 1 (mTORC1), which appears to be a 
central regulator of contraction-induced enhancement of protein translation efficiency and 
capacity (22, 28, 29, 42).  In one study, overexpression of the α7BX2 integrin in muscle resulted 
in suppression of mTORC1 and p70S6K activity immediately and 3 hours following an acute 
bout of eccentric exercise (3).  In subsequent studies, however, overexpression of the α7BX2 
integrin increased mTOR and p70S6K phosphorylation at later time points following both acute 
and multiple (3x/wk for 4 wks) bouts of downhill running (38, 50). Enhancement of myofiber 
CSA and myofibrillar protein content has been noted in α7Tg muscle post-exercise, but no 
significant changes in muscle wet weight have been observed (38, 50). This is not entirely 
unexpected given the aerobic nature of the activity. Thus, downhill running, while an excellent 
model for the assessment of muscle damage and repair post-exercise, is not an appropriate model 
for evaluation of muscle growth. 
Surgical removal of the gastrocnemius and soleus complex can result in chronic 
mechanical loading (CML) of the plantaris muscle and notable increases in muscle wet weight 
and myofiber hypertrophy. CML represents a rapid and convenient model for elucidating the 
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mechanistic basis for growth. However, damage associated with excess strain can also initiate a 
robust repair process, and the overlap in timing between both events can make it difficult to 
discern the early molecular changes responsible for each (8, 18, 22). Myotenectomy (MTE) is a 
modified form of gastrocnemius ablation in which the gastrocnemius is severed and the soleus is 
kept intact. This modification reduces the load on the plantaris which helps mitigate some of the 
damage to the fiber. Thus, we applied this model to mice overexpressing the α7 integrin to 
address the extent to which the integrin can regulate strain-induced growth. An early time point 
(1D post-MTE) was chosen to evaluate the early signaling changes associated with mechanical 
strain. We also examined the plantaris muscle 14D post-MTE to determine phenotype and 
functional changes that occur with α7 integrin overexpression and loading. This study 
demonstrates that MTE initiates a rapid hypertrophic response in both WT and α7Tg muscle, yet 
the response is augmented in α7Tg mice.        
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3.3 Materials and Methods 
Animals and chronic overload 
All mice were housed in the Beckman Institute animal facility at the University of Illinois 
in a temperature-controlled, pathogen-free animal room maintained on a 12:12 light-dark cycle. 
The animals were fed standard laboratory chow and water ad libitum. Protocols for animal use 
were approved by the Institutional Animal Care and Use Committee (IACUC) of the University 
of Illinois at Urbana-Champaign. Mice overexpressing the rat α7 integrin subunit under the 
control of a muscle-specific promoter (MCK:α7BX2 integrin) and littermate controls were bred 
and maintained as previously described (3).  
Young adult (6 mo) WT and α7Tg male mice were randomly assigned to receive 
myotenectomy (MTE) or sham (sham) surgery on both hind legs. Sham surgery included the 
incision of the skin and fascia surrounding the posterior muscle compartment.  Animals were 
weighed and then anesthetized with 2-3% isoflorane with 95-99% oxygen via inhalation.  The 
hindlimbs were shaved using electric hair clippers, followed by disinfecting with betadine 
solution and alcohol wipes. The incisions were closed using PDS sutures and Vetbond (3M, St. 
Paul, MN).  The mice received a subcutaneous injection of buprenorphine (1mg/kg) before 
surgery and every 12 hours for 72 hours. The incisions were monitored for healing and the mice 
were weighed every day for 7 days post-surgery. 
Animals were sacrificed 1 (1D) (n=8-9) or 14 days (14D) (2-5) post-surgery for analysis.  
Mice were euthanized via carbon dioxide asphyxiation. One plantaris muscle and one soleus 
muscle were frozen in liquid nitrogen cooled isopentane for immunohistochemistry (IHC), and 
the plantaris and soleus from the other leg were snap frozen in liquid nitrogen for western 
blotting. 
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Muscle weights and force measurements 
 Mice were subject to maximal tetanic force measurement prior to sacrifice at 14D post-
MTE.  While anaesthetized with isoflurane, the right hind limb was re-shaven and the peroneal 
nerve was identified and severed to prevent recruitment of the anterior crural muscles. The right 
foot of each mouse was attached to the foot pedal located on the shaft of the servomotor (model 
300B-LR; Aurora Scientific, Aurora, Ontario, Canada). Two platinum electrodes were then 
inserted subcutaneously on either side of the sciatic nerve to deliver voltage at 100 Hz to the 
nerve and elicit isometric tetanic contractions of the soleus and plantaris muscles.  Measurements 
were repeated every 90 seconds until a drop in force was detected, with no more than 4 trials per 
animal.  The highest magnitude force measured was recorded and expressed relative to body 
weight of the animal.  Muscles subject to force measurement were used for IHC so as not to 
impact intracellular signaling as assessed by western blot.  Immediately post-euthanasia prior to 
freezing, wet plantaris and soleus muscle weights were recorded 1D and 14D post-MTE. 
Western blotting 
Plantaris and soleus muscles were placed directly in 500 uL of ice-cold lysis buffer 
containing HEPES (20 mM), EGTA (2 mM), β-glycerophosphate (50 mM), DTT (1 mM), 
Na3VO4 (1 mM), Triton X-100 (1%), glycerol (10%), leupeptin (10 µM), benzamidine (3 mM), 
pepstatin A (5 µM), aprotinin (10 µg/ml), PMSF (1 mM).  The tissue was disrupted using a hand 
held homogenizer and the homogenates were rotated at 4°C for 1 h and centrifuged at 14,000g 
for 5 minutes at 4°C.  The detergent soluble fraction in the supernatant was removed for western 
blotting analysis, and the concentration of protein was determined with the Bradford protein 
assay using bovine serum albumin (BSA) as the standard curve.  Equal amounts of protein (30 
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µg) were subjected to SDS-PAGE western blotting using 8% acrylamide gels, and transferred to 
nitrocellulose membranes. Equal protein loading was verified by PonceauS staining.    
Membranes for detection of α7 integrin were blocked in Tris-buffered saline (pH 7.8) 
with Tween20 (TBST), containing 5% non-fat dry milk (NFDM) overnight, followed by a 
primary incubation in purified α7 CDB 347 polyclonal rabbit anti-rat antibody (1:1000) for 1 
hour.  Membranes for ATF6α, BiP, CHOP, and Spliced XBP-1 were blocked for 1 hr in 5% 
NFDM in TBST, with the respective primary antibodies suspended in 5% NFDM overnight.  The 
remaining western blots utilized blocking with 5% BSA, and primary antibodies suspended in 
2.5% BSA.  Horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch 
Laboratories, West Grove, PA) were applied for 1 hour at 1:10,000 for α7, and 1:3000 for the 
other proteins. Bands were detected using SuperSignal West Dura Extended Duration Substrate 
(Thermo Scientific, Rockford, IL) and a Bio-Rad ChemiDoc XRS system (Bio-Rad, Hercules, 
CA). Quantification was completed using Quantity One software (Bio-Rad). All bands were 
normalized to PonceauS. 
Antibodies were obtained from Enzo Life Sciences (GRP78/HSPa5/BiP), Santa Cruz 
Biotechnology (ATF6α, RPL13a, Spliced XBP-1), and Cell Signaling (p38-MAPK 
[Thr180/Tyr182], YAP, HSP70, CHOP, eIF2α[Ser51], total and phospho FAK[Y397], total and 
phospho ILK[Ser246], total and phospho AKT[Ser473)], total and phospho mTOR[Ser2448], 
total and phospho p70S6K[Thr389], p70S6K[Thr421], total and phospho S6[Ser235/236], and 
phospho 4E-BP1[Ser65]), or generated in house (α7 integrin CDB 347 polyclonal rabbit anti-rat 
antibody).  
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Immunohistochemistry 
Muscles were divided at the midline along the axial plane and three transverse 
cryosections per sample (16 µm nonserial sections, each separated by a minimum of 40 µm) 
were cut for each histological assessment using a CM3050S cryostat (Lecia, Wezlar, Germany). 
Sections were placed on microscope slides (Superfrost; Fischer Scientific, Hanover Park, IL) and 
stored at -80°C before staining.  Prior to staining, slides were thawed, and then fixed in acetone 
at -20°C for 10 minutes.  For anti-α7 integrin staining, CDB 347 primary antibody was used.  
Fibers with a centrally located nuclei (CLN) were identified using a DAPI/laminin (anti-laminin 
α1, R&D Systems) co-stain, with the number of nuclei at the center of the fiber normalized to 
total fibers counted.  FITC-conjugated mouse anti-IgG (FI2000, Vector, Burlingame, Ca) 
staining was used to determine myofiber damage, by counting the number of IgG positive fibers 
and normalizing to total fiber number. 
For fiber type-specific cross sectional area (CSA) analysis, sections were stained with 
anti-myosin heavy chain 1 (BA.D5), anti-myosin heavy chain 2A (SC.71), anti-myosin heavy 
chain 2B (BF.F3), and anti-myosin heavy chain 2X (6H1) antibodies obtained from 
Developmental Studies Hybridoma Bank (Iowa City, IA, USA) (24). The sections were co-
stained with anti-dystrophin (Abcam) to outline the myofiber.  Due to loss of dystrophin at the 
membrane at 1D post-MTE, fiber type specific staining was not quantifiable and laminin staining 
was used to assess all fiber CSA at this time point.  
Images of the entire sections (5-10 images/section) were acquired at 10x magnification 
(Leica DMRXA2 microscope, Zeiss AxioCam digital camera and software) and imported into 
Adobe Photoshop (CS5 Extended) for assessment.  For CSA measurements, up to 150 fibers per 
fiber type (up to 300 total fibers for 1D post-MTE groups) were manually circled using the 
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magnetic lasso tool, which grabs the positively stained pixels in order to limit subjectivity and 
error. The CSA for each fiber was recorded in a measurement log. The results for each sample 
were then averaged.  Histograms were generated using conditional statement equations in Excel.  
Statistical analysis 
All data is presented as the mean ± SEM. Two-way ANOVA was used to identify 
interactions and main effects (MTE and Genotype).  No differences were detected in muscle 
weights or signaling data for 1D and 14D shams within WT and α7Tg groups, thus 1D and 14D 
sham data was combined for each genotype. Time points (1D and 14D) were assessed 
independently compared to sham. A least significant difference (LSD) post-hoc comparison was 
performed when an interaction was detected.  Data is considered significant at P<0.05. (SPSS, 
version 16). 
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3.4 Results 
α7 integrin expression and muscle wet weight 
Creatine kinase is preferentially expressed in fast twitch fibers. Thus, overexpression of 
α7B integrin protein by the MCK promoter is observed in fast twitch muscle.  Figure 3.1A 
demonstrates that in contrast to endogenous mouse α7B integrin (detected by CDB antibody; left 
panel) which is preferentially expressed in the soleus compared to the gastrocnemius in WT mice, 
rat α7B integrin (detected by rat-specific O26 antibody; right panel) is preferentially expressed 
by the gastrocnemius. Consistent with this observation, we find that total α7B integrin protein is 
higher in fast-twitch plantaris muscle compared to slow-twitch soleus muscle in MCK:α7BX2 
transgenic mice (Genotype Effect, 1D & 14D Post: P<0.001) (Figure 3.1B).  MTE did not 
significantly alter integrin expression in WT mice at 1D or 14D (MTE Effect, 1D Post: P=0.429, 
14D Post: P=0.621). 
Plantaris muscle weights are increased in both WT and α7Tg mice 1D post-MTE, with 
significantly more growth observed in α7Tg muscle (58% increase vs. sham) than in WT muscle 
(26% increase vs. sham) (Genotype*MTE interaction, P=0.008) (Figure 3.1C).  Changes in 
muscle mass between 1D and 14D post-MTE were minimal, yet the transgenic plantaris (68%) 
remained elevated compared to WT (38%) (Genotype*MTE interaction, P=0.018) (Figure 3.1C).  
Consistent with lack of α7 integrin overexpression in the soleus, muscle weights are increased 
65% from sham 1D post-MTE with no difference between genotypes (MTE Effect, 1D & 14D 
Post: P<0.001) (Figure 3.1D). In addition, there was no further increase at 14D.   Maximal 
tetanic force was not significantly different between WT and transgenic at 14D post-MTE 
(Figure 3.1E). 
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Damage and stress 
A representative image of IgG stained fibers in the plantaris muscle 1D post-MTE is 
provided in Figure 3.2A. Damage associated with MTE was variable between mice and muscle 
groups and significant differences were not detected (Figure 3.2A). p38 phosphorylation and 
HSP70 content were evaluated in plantaris muscle as additional indices of stress at 1D post-MTE. 
p38 phosphorylation was increased in WT (7.1 fold increase vs. sham) and α7Tg (3.2 fold) 
muscles after MTE, and phosphorylation was reduced in α7Tg muscle (MTE Effect, P=0.001; 
Genotype Effect, P=0.05) (Figure 3.2B). HSP70 content was increased with MTE, but no 
significant differences were detected by genotype (WT: 8.5 fold, TG: 3.2 fold; MTE Effect, 
P=0.001) (Figure 3.2C). The percentage of fibers with a centrally located nuclei (CLN) was 
assessed at 14D post-MTE as an additional evidence of prior muscle damage. The percentage of 
fibers with a CLN was increased with MTE, but no significant differences were detected by 
genotype (WT: 7.8 fold, TG: 2.8 fold; MTE Effect, P=0.013) (Figure 3.2D).   
Myofiber growth and fiber type shift 
Myofiber cross sectional area (CSA) was assessed in the plantaris muscle at 1D and 14D 
post-MTE. No significant differences were detected at either time point as a result of MTE or 
genotype.  A trend towards an increase in the average CSA was detected at 1D post-MTE (MTE 
Effect, P=0.07) (Figure 3.3A). In addition, there was a significant increase in the quantity of 
large myofibers at 1D post-MTE (>2,000µm2: MTE Effect, P=0.05) (Figure 3.3A).  No 
significant differences were detected in fiber type-specific CSA as a result of MTE or genotype 
(Figure 3.3C). A significant increase in total myofiber number per plantaris cross section was 
evident at 14D post-MTE, and there were more myofibers per cross section detected in the α7Tg 
groups (MTE Effect, P=0.013; Genotype Effect, P=0.038) (Figure 3.4A).  An increased trend 
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was observed for the percentage of Type I fibers in α7Tg muscle 14D post-MTE (1.4% in WT vs 
18.2% in α7Tg; Genotype*MTE Interaction, P=0.159) (Figure 3.4B), and these Type I fibers 
appeared larger than WT based on the fiber size distribution (Figure 3.4C).  
Integrin and hypertrophic signaling 
FAC and mTORC1 signaling was evaluated to understand the mechanistic basis for 
enhanced muscle mass observed in α7Tg plantaris muscle (Figure 3.5A).  FAK and ILK 
phosphorylation increased in WT and α7Tg 1D post-MTE, with less FAK phosphorylation noted 
in α7Tg muscle compared to WT (Phospho:Total FAK: MTE Effect, P=0.002, Genotype Effect, 
P=0.018; Phospho:Total ILK: MTE Effect, P=0.033) (Figure 3.5B).  At 14D post-MTE, FAK 
phosphorylation decreased below baseline values in both groups, whereas ILK phosphorylation 
remained elevated in both groups (Phospho:Total FAK: MTE Effect, P<0.001; Phospho:Total 
ILK: MTE Effect, P=0.001). 
AKT and S6 phosphorylation were increased in both WT and α7Tg plantaris muscle 1D 
post-MTE, but mTOR and p70S6K (Thr389) phosphorylation were differentially regulated such 
that an increase was noted in WT compared to α7Tg (Phospho:Total AKT: MTE Effect, 
P<0.001; Phospho:Total S6: MTE Effect, P<0.001; Phospho:Total mTOR: MTE*Genotype 
Interaction, P=0.031; Phospho:Total p70S6K: MTE*Genotype Interaction, P=0.004) (Figure 
3.5B). AKT, mTOR and p70S6K phosphorylation returned to baseline in both WT and α7Tg 
muscle by 14D. However, S6 activation remained elevated in the WT group (MTE*Genotype 
Interaction, P=0.013).  
4E-BP1(Ser65) phosphorylation was elevated in the α7Tg plantaris (70%), but not WT 
1D post-MTE (MTE*Genotype Interaction, P=0.032).  No significant differences in 
phosphorylation of 4E-BP1(Ser65) were noted 14D post-MTE, but it appeared to increase in the 
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WT while returning to baseline in the α7Tg plantaris (Figure 3.5B). Total 4E-BP1 was also 
assessed separately with no differences noted with MTE or genotype at 1D post, but there was an 
increase in total 4E-BP1 for both groups 14D post-MTE (Total 4E-BP1:PonceauS: MTE Effect, 
P=0.001) (data not shown).  eIF2α phosphorylation was decreased in both WT and α7Tg 1D 
post-MTE (Phospho eIF2α: PonceauS: MTE Effect, P=0.019) and increased in both groups 14D 
post-MTE (Phospho eIF2α: PonceauS: MTE Effect, P=0.006) (Figure 3.6C). 
The transcriptional co-activator yes-associated protein (YAP) can regulate skeletal 
muscle mass and myofiber CSA in both slow and fast fiber types via increased protein synthesis 
in a rapamycin insensitive manner (21, 47).  YAP total protein was increased in the α7Tg 
plantaris as compared to WT (YAP:PonceauS: Genotype Effect, 1D: P=0.012, 14D: P=0.153) 
(Figure 3.5B).  Unlike traditional synergist ablation, MTE did not increase total YAP.  However, 
our time points were likely too early (1D) and too late (14D) to detect transient changes with 
mechanical loading (21).  
BiP and the unfolded protein response 
We recently reported elevation of binding immunoglobulin protein (BiP) expression in 
α7Tg muscle, a heat shock protein responsible for coordination of the unfolded protein response 
(UPR) (also known as 78 kDa glucose-regulated protein, GRP-78; or heat shock 70 kDa protein 
5, HSPa5) (27, 41, 44, 48).  In this study, we also observe a significant enhancement of BiP 
expression in α7Tg muscle (BiP:PonceauS: 1D Post-MTE: Genotype Effect, P=0.008) (Figures 
3.6A-3.6B). BiP expression was not altered as a result of MTE in either group at 1D, and was 
increased to the same extent in both at 14D post-MTE (BiP:PonceauS: 14D Post-MTE: MTE 
Effect, P=0.001; Genotype Effect, P=0.076).  In contrast to our recent study that demonstrated 
the ability for the α7 integrin to initiate a beneficial UPR, no differences were noted in total 
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ATF6α, Spliced XBP-1, or CHOP by genotype. Spliced XBP-1 was decreased 14D post-MTE in 
both groups (Spliced XBP-1:PonceauS: MTE Effect, P<0.001) and CHOP was increased in both 
groups at both time points (CHOP:PonceauS: 1D Post-MTE: MTE Effect, P<0.001; 14D Post-
MTE: MTE Effect, P=0.008) (Figure 3.6C).  
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3.5 Discussion 
The results from this study demonstrate that the α7 integrin positively regulates muscle 
weight in the plantaris 1D and 14D post-MTE. The lack of transgene expression and subsequent 
lack of increase in muscle weight in the α7Tg soleus provides compelling evidence that the α7 
integrin can directly regulate muscle remodeling. While the precise mechanism of α7 integrin-
mediated remodeling remains elusive, our data suggest that overexpression of the α7 integrin 
mitigates myofiber stress and attenuates mTOR signaling in response to strain associated with 
chronic loading. Elevations in total YAP and BiP protein content, in concert with 
phosphorylation of 4E-BP1 (Ser65), may augment the adaptive response to loading in α7Tg mice. 
Phenotype changes: muscle weight, fiber CSA, fiber quantity, strength, and fiber type shifting 
In the current study, an increase in plantaris weight is observed 1D post-MTE, with 
minimal changes in mass occurring between 1D and 14D time points.  Most studies that 
incorporate traditional synergist ablation (SA) in mice do not report weight changes at this early 
time point, so direct comparison between SA and MTE is difficult. However, Chaillou et al. 
reported similar increases in muscle weight in mice as early as 1D post-SA (8). In addition, the 
range of growth observed in WT mice at 1D and 14D post-MTE in our study is very similar to 
data obtained in mice 3-14D post-SA by other groups (17, 36, 39, 43). This was unexpected, as 
MTE distributes load evenly among the soleus and plantaris, and we anticipated a submaximal 
response. Regardless, we believe the increase in muscle weight in α7Tg muscle at 1D likely 
reflects accumulation of myofibrillar protein content rather than water, as α7Tg muscle is highly 
resistant to damage, inflammation, and stress (3, 5, 38). Suppression of damage and degradation 
may, in fact, provide the underlying basis for increased growth in the context of resistance 
exercise training (12, 45).  Fiber CSA was not different between WT and α7Tg muscle at 14D 
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post-MTE, however an increase in fiber number per section was observed.  These changes may 
be attributed to longitudinal hypertrophy (sarcomere addition) or new fiber synthesis as 
previously demonstrated in α7Tg muscle following an acute bout of eccentric exercise (38). 
An increase in tetanic force was not detected in α7Tg compared to WT at 14D post-MTE. 
However, sciatic nerve stimulation during the assessment recruits both the soleus and plantaris 
muscles, which is important to consider given the fact that α7 integrin protein expression and 
preferential growth are only elevated in the plantaris muscle. Thus, an ex vivo approach is 
necessary to provide a specific and accurate measure of plantaris muscle strength.  
Evidence of an oxidative fiber type shift and preferential increase in the size of resultant 
Type I fibers was observed in the α7Tg group 14D post-MTE.  Increased oxidation during 
chronic loading would be advantageous from an energetic standpoint and this phenomena has 
been previously reported by others with long-term chronic loading (usually >2 weeks of loading) 
(17, 36).  Interestingly, FAK overexpression in rat soleus muscle can increase markers of 
mitochondrial respiration and MHC1 expression while also increasing myofiber CSA (15). Thus, 
the α7 integrin appears to facilitate an adaptive response that includes both fiber type shifting and 
growth.  
The α7 integrin may promote growth via an mTORC1 independent mechanism 
Focal adhesion complex proteins FAK and ILK appear to facilitate the growth response 
to mechanical loading (9, 15, 16, 34).  Our results indicate despite increased α7 integrin content, 
FAK phosphorylation is increased to a greater extent in WT compared to α7Tg plantaris muscle 
1D post-MTE, and ILK phosphorylation is not enhanced in α7Tg muscle compared to WT. 
Either these signaling events occur in α7Tg muscle at an earlier time point (<1 day) or they do 
not facilitate α7 integrin subunit-mediated growth. Alternatively, FAK phosphorylation may 
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occur as a result of membrane damage and loss of dystrophin following mechanical strain (15, 
35).  It is possible that this transient event is necessary to stabilize the actin cytoskeleton in 
preparation for mechanosensing, additional steps that may not be necessary in α7Tg muscle that 
has maintained the actin stress fiber network (30). 
mTOR kinase activity has previously been shown to be essential for maximal intrinsic 
myofiber growth through activation of p70S6K(Thr389) signaling, yet recent studies 
demonstrate myofiber growth may also be partially mTOR independent (18, 21 22, 47). In the 
current study, we observe attenuation of mTOR and p70S6K(Thr389) phosphorylation in the 
α7Tg plantaris during a period of rapid hypertrophy, suggesting that muscle growth observed in 
this study may not be due to an increase in mTORC1 activity.  Despite lack of mTOR or p70S6K 
activity, 4E-BP1(Ser65) phosphorylation is enhanced in α7Tg muscle 1D post-MTE. 
Phosphorylation of 4E-BP1 on Serine 65 is primed by phosphorylation on Serine 101. This site is 
rarely studied and Ser101 specific antibodies are not commercially available (46). In a unique 
study utilizing electrophoresis mobility shift assays and a variety of inhibitors, Liu et al. 
demonstrates phosphorylation of 4E-BP1 (Ser101) is increased during contraction in an 
mTORC1 independent fashion. In contrast, traditionally studied sites regarded to be regulated by 
mTORC1 (Thr37/46, Ser65, Thr70) are not phosphorylated until the cessation of contraction, 
suggesting their activation is likely due to stimulation by growth factors and amino acids (37).  
In addition, kinases other than mTOR may directly phosphorylate 4E-BP1 on Serine 65 (2, 42).  
In the context of these studies, we speculate that the observed elevation of phosphorylated 4E-
BP1 (Ser65) in the α7Tg plantaris 1D post MTE is due to an α7 integrin dependent mechanism, 
either acting directly on Ser65 or via priming by enhanced activation of Ser101.  The result of 
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this event would be increased initiation of protein translation through the release of 4E-BP1 
association with eIF4E and formation of the eIF4F complex. 
The transcriptional co-activator yes-associated protein (YAP) can translocate to the 
nucleus to activate TEA domain family members (TEADs 1-4) and other transcription factors 
(32). Actin stress fiber formation promotes YAP dephosphorylation and translocation to the 
nucleus, while de-stabilization can cause cytoplasmic retention and maintenance of 
phosphorylation that can result in ubiquitin-mediated degradation (14, 26, 32, 47, 49). 
Specifically, YAP phosphorylation on Ser 112 can result in degradation via FoxO/Atrogin-1 and 
an additional phosphorylation site (Ser381) also mediates YAP degradation through casein 
kinase 1 in the cytoplasm (26, 32, 47). Total YAP protein can increase with mechanical overload, 
and YAP overexpression can directly regulate muscle mass in the absence of load (21, 47). In 
addition, YAP overexpression can promote an increase skeletal muscle mass and myofiber CSA 
in both slow and fast fiber types via increased protein synthesis in a rapamycin insensitive 
manner (21, 47).  In the current study, YAP is not enhanced in the α7Tg plantaris, but is 
maintained at 1D post-MTE compared to WT.  We speculate that overexpression of the α7 
integrin can stabilize the actin cytoskeleton and promote translocation of YAP that protects it 
from degradation. The ability for the integrin to directly regulate SLC7A5 expression, a 
downstream effector of YAP, provides some support for this hypothesis (41). We are currently 
examining YAP phosphorylation and translocation with integrin overexpression both in vivo and 
in vitro.   
The α7 integrin does not alter the unfolded protein response 
The unfolded protein response (UPR) occurs during times of endoplasmic reticulum (ER) 
stress, when the rate of translation at the ER results in accumulation of misfolded or irregular 
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proteins (27, 44, 48).  An important endoplasmic reticulum-resident chaperone protein, BiP, 
recognizes the accumulation of misfolded proteins and initiates the UPR.  This slows protein 
synthesis through modulation of eIF2α phosphorylation, and increases transcription of chaperone 
proteins through ATF6α and XBP-1, thus mitigating ER and cell stress and increasing survival 
(27, 44, 48).  We previously detected an elevation in BiP mRNA and protein in α7Tg skeletal 
muscle, which coincided with a beneficial UPR post-eccentric exercise. In the current study, we 
verify the increase in BiP protein, yet no changes in the UPR were observed. Thus, it is unlikely 
that UPR is responsible for enhanced muscle mass observed in α7Tg plantaris 1D post-MTE.   
Conclusion 
The purpose of this study was to examine the impact of the α7BX2 integrin on skeletal 
muscle hypertrophy following chronic mechanical loading. We demonstrate that transgenic 
overexpression of the α7 integrin augments skeletal muscle mass 1D and 14D post-MTE, and 
that these changes are not due to an enhancement in mTORC1 signaling. The results from this 
study suggest that the α7β1 integrin initiates remodeling through reductions in skeletal muscle 
stress, and enhancements in the phosphorylation of 4E-BP1(Ser65) and total YAP.   
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3.9 Figure Legends & Figures 
Figure 3.1 
 
Figure 3.1. Verification of transgene expression and impact of the α7 integrin on muscle 
weight and force.  The MCK promoter increases α7 rat integrin protein in the gastrocnemius (A) 
and plantaris (B) but not the soleus (A&B).  The soleus and the plantaris weights were examined 
1D (C) and 14D (D) post-MTE.   Maximal tetanic force of the posterior muscle compartment 
was measured 14D post-MTE (E). * Indicates a genotype main effect (P ≤ 0.05).  # Indicates a 
MTE main effect (P ≤ 0.05). ‡ vs. WT (P ≤ 0.05).  ^ vs. genotype matched sham (P ≤ 0.05).  All 
values are mean ± SEM.  Western blotting data are expressed relative to WT sham for each 
muscle. 
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Figure 3.2 
 
Figure 3.2. The α7 integrin protects from myofiber stress after MTE.  Muscle damage to the 
soleus and plantaris identified by immunohistochemistry for IgG (A) and myofiber stress in the 
plantaris by western blotting for phospho p38 MAPK (B) and HSP70 (C) were assessed 1D post-
MTE.  Plantaris myofiber repair identified by CLN was assessed 14D post-MTE (D). * Indicates 
a genotype main effect (P ≤ 0.05).  # Indicates a MTE main effect (P ≤ 0.05). ‡ vs. WT (P ≤ 0.05).  
^ vs. genotype matched sham (P ≤ 0.05).  All values are mean ± SEM.  Western blotting data are 
expressed relative to WT sham for each muscle. 
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Figure 3.3 
 
Figure 3.3. α7 integrin overexpression increases myofiber size 1D post-MTE. Average 
myofiber CSA and fiber size distributions were assessed 1D (A) and 14D (B) post-MTE.  
Average myofiber CSA by fiber type was assessed 14D post-MTE (C). * Indicates a genotype 
main effect (P ≤ 0.05).  # Indicates a MTE main effect (P ≤ 0.05). ‡ vs. WT (P ≤ 0.05).  ^ vs. 
genotype matched sham (P ≤ 0.05).  All values are mean ± SEM.   
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Figure 3.4 
 
Figure 3.4. The α7 integrin increases myofiber number and promotes an oxidative fiber 
type shift 14D post-MTE.  Myofiber number (A), fiber type distribution (B), and type I fiber 
size distribution (C) were assessed 14D post-MTE.  * Indicates a genotype main effect (P ≤ 0.05).  
# Indicates a MTE main effect (P ≤ 0.05). ‡ vs. WT (P ≤ 0.05).  ^ vs. genotype matched sham (P 
≤ 0.05).  All values are mean ± SEM.   
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Figure 3.5 
 
Figure 3.5. The impact of the α7 integrin on hypertrophic signaling.   Representative 
immunoblots of integrin signaling, hypertrophic signaling, and total YAP 1D post-MTE (A). 
Activation of FAK, ILK, AKT, mTOR, p70S6K, S6, 4E-BP1, and total YAP were assessed by 
western blot 1D and 14D post-MTE (B). * Indicates a genotype main effect (P ≤ 0.05).  # 
Indicates a MTE main effect (P ≤ 0.05). ‡ vs. WT (P ≤ 0.05).  ^ vs. genotype matched sham (P ≤ 
0.05).  All values are mean ± SEM.  Data are expressed relative to WT sham for each muscle. 
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Figure 3.6 
 
Figure 3.6.  α7 integrin overexpression promotes increased BiP protein without altering the 
unfolded protein response.  Representative immunoblots of BiP and UPR signaling 1D post-
MTE (A). BiP protein (B) and UPR signaling (C) was assessed by western blot 1D and 14D 
post-MTE. * Indicates a genotype main effect (P ≤ 0.05).  # Indicates a MTE main effect (P ≤ 
0.05). ‡ vs. WT (P ≤ 0.05).  ^ vs. genotype matched sham (P ≤ 0.05).  All values are mean ± SEM.  
Data are expressed relative to WT sham for each muscle. 
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4.1 Abstract 
Laminin (LM) is the preferential ECM ligand for the α7β1 integrin, and binding regulates 
the structure, function, and survival of skeletal muscle. The laminin α1β1γ1 (LM-111) isoform is 
abundantly expressed during embryogenesis, but significantly declines during postnatal 
development. Exogenous LM-111 replacement can initiate myofiber repair and ameliorate 
pathology in dystrophic skeletal muscle.  However, the regenerative influence of LM-111 on 
aged muscle has not been evaluated. Thus, the purpose of this study was to determine the extent 
to which LM-111 can improve age-related deficits in repair and growth in response to a 
mechanical stimulus. Young (3 mo) and aged (22 mo) WT mice received an i.p. injection of 
saline or human LM-111 (1 mg/kg). One week later, the myotendinous junction of the 
gastrocnemius muscle was removed via myotenectomy (MTE), thus placing a chronic 
mechanical stimulus on the remaining plantaris muscle.  Two weeks post-MTE, muscles were 
dissected, weighed and evaluated for indices of repair and growth. LM-111 enhanced α7B 
integrin subunit localization and expression at the sarcolemma, and reduced the inflammatory 
response and increased repair in aged muscle following MTE. LM-111 treatment also restored 
the growth response to loading in aged mice. Finally, we demonstrate that addition of collagen to 
a laminin-based substrate effectively eliminates the ability for myotubes to grow in response to 
mechanical strain in vitro. The results from this study suggest that lack of laminin interaction 
with an integrin binding partner at the sarcolemma may provide the basis for lack of 
mechanosensing and resistance to growth in aged skeletal muscle. In addition, LM-111 may 
represent a novel therapeutic approach to sarcopenia. 
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4.2 Introduction 
The Department of Health and Human Services Administration on Aging estimates there 
will be 72.1 million people older than 65 years by 2030 (19% of the US population), twice as 
many as in the year 2000 (1, 44). Aging is concomitant with biochemical, structural, and 
functional alterations in skeletal muscle that result in loss of satellite cell activation, increased fat 
and collagen deposition, reduced strength, and myofiber atrophy (33, 39).  Today, ~45% of 
individuals over age 75 are diagnosed with sarcopenia, defined as the age-related loss of muscle 
mass and function. The primary cause of sarcopenia is complex and not well understood, but 
may include stem cell dysfunction and anabolic resistance to a growth stimulus (10, 19, 50, 51). 
Lack of muscle protein synthesis and growth has been observed in response to exercise in older 
adults and the basis for resistance is not known  (2, 11, 17, 28, 32).  Due to absence of 
information regarding mechanism, therapeutic strategies to combat the age-associated decline in 
sensitivity to mechanical loading currently do not exist.  
Dystrophin and integrins in the sarcolemma provide the primary linkage systems 
necessary for attachment of the myofiber to the surrounding extracellular matrix (ECM), and 
both possess the capacity to serve as essential mechanosensors for skeletal muscle (5, 6, 7, 27, 
31). However, the loss of dystrophin and compensatory upregulation of the integrin at the 
membrane in response to contraction suggest that the integrin serves as the predominant 
mechanosensor during loading (6).  The α7β1 integrin isoform is highly expressed in skeletal 
muscle, and the primary role of this transmembrane heterodimer is to link laminin in the basal 
lamina with the actin cytoskeleton at the costamere (3, 5, 7).  The α7β1 integrin is essential for 
maintenance of muscle integrity, as α7 integrin knockout mice are highly susceptible to muscle 
damage following contraction, and conversely, muscle-specific transgenic overexpression of the 
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α7β1 integrin can prevent damage, reduce inflammation, increase satellite cell accumulation, and 
accelerate myofiber growth in young mice in response to acute or repeated bouts of eccentric 
exercise (5, 6, 34, 58). Despite the unequivocal role for the integrin in the maintenance of 
skeletal muscle integrity, no information exists regarding α7β1 integrin localization and function 
in the context of normal muscle aging.  
The laminin isoform LM-111 (α1β1γ1) is one of the first extracellular matrix proteins 
expressed during embryogenesis.  LM-111 can coordinate a variety of biological activities, 
including stem cell migration, nerve growth, angiogenesis, matrix remodeling and basement 
membrane assembly (16, 25, 40, 49, 58). However, expression declines during postnatal 
development and is absent in adult tissues. Exogenous administration of this early laminin 
isoform can offer protection against pathology in mice with muscular dystrophy and enhance 
muscle repair following eccentric exercise or cardiotoxin injury (20, 45, 53, 58).  These benefits 
occur in part due to the ability for LM-111 to increase α7β1 integrin expression and promote 
satellite cell expansion (45, 58). The potential of LM-111 to promote α7 integrin protein 
expression and subsequently increase myofiber growth in response to a mechanical stimulus has 
not been investigated.   
In this study, we first evaluated the impact of α7 integrin subunit overexpression on the 
hypertrophic response to chronic loading in aged mice. No beneficial increase in growth was 
noted, likely due to loss of α7 integrin localization at the sarcolemma in aged muscle. Thus, the 
primary purpose of this study was to evaluate the extent to which LM-111 administration could 
rescue α7 integrin localization at the membrane and recover the hypertrophic response to loading. 
The results from this study suggest that systemic administration of LM-111 significantly altered 
total α7 integrin protein expression and localization in aged mice, subsequently restoring the 
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anabolic response to a chronic mechanical stimulus. These observations and additional in vitro 
analyses suggest that microenvironment can significantly impact mechanosensing and net muscle 
mass following a period of loading.   
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4.3 Materials and Methods 
Animals 
Mice were kept on a 12 hr dark/light cycle (lights on 07:00 to 19:00 h) in a pathogen free, 
temperature-controlled facility and fed standard laboratory chow ad libitum.  Protocols for 
animal use were approved by the Institutional Animal Care and Use Committee (IACUC) of the 
University of Illinois at Urbana-Champaign, and National Institutes of Health guidelines for the 
care and use of laboratory animals were strictly followed. Mice overexpressing the rat α7 
integrin subunit under the control of a muscle-specific promoter (MHCK7:α7BX2; α7Tg) and 
littermate WT controls (n=24) were bred and aged to 12 or 24 months in house. MCK-driven 
cassettes (MHCK7) which incorporate the deletion and addition of enhancer/promoter regions of 
murine creatine kinase and α-myosin heavy chain genes, including a strong cardiac muscle gene 
enhancer (188 bp mouse α-MHC), were used to create MHCK7:α7BX2 mice (C57BL/6 strain). 
This promoter allows for expression in slow- and fast-twitch muscle, as well as the heart and 
diaphragm (47). For LM-111 studies, young adult (3 month old) and aged (22 month old) 
C57BL/6J mice (n=20) were acquired from the National Institute of Aging (NIA). 
For the α7 integrin overexpression study, mice were randomly assigned to one of 8 
groups: 12 mo WT or α7Tg sham (young and aged, n=3/group), 24 mo WT or α7Tg sham 
(young and aged, n=3), 12 mo WT or α7Tg MTE (young and aged, n=3), and 24 mo WT or 
α7Tg MTE (young and aged, n=3).  Each group included at least 1 male, and 1 female based on 
availability from litters born.  For the LM-111 study, mice were randomly divided into one of six 
groups: sham (young and aged, n=4), MTE-saline (young, n=4; aged, n=6) and MTE-laminin 
(young and aged, n=8).  Each group included males and females.  
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Surgery 
Animals were weighed and anaesthetized with 2-3% isoflurane with 95-99% oxygen as 
vehicle. The hindlimb was shaved from the ankle to the hip using a pair of electric hair clippers. 
The skin was disinfected with betadine solution and alcohol wipes. Under aseptic conditions, the 
myotendinous junction and the base of the gastrocnemius muscle were removed (myotenectomy, 
or MTE), which places chronic load on the remaining soleus and plantaris muscles, as previously 
described (35). The skin incision was closed with PDS sutures and Vetbond (3M, St. Paul, MN).   
For the LM-111 study, animals received a single i.p. injection of saline or human LM-
111 (1 mg/kg) (Sigma-Aldrich, St. Louis, MO) one week prior to MTE. All animals were given a 
subcutaneous injection of Buprenorphine (1 mg/kg) right before the surgery and twice daily for 
72 hours after the procedure. The mice were checked for movement and weighed every day for 7 
days post-surgery. The plantaris muscles were harvested and weighed two weeks post-surgery 
and processed accordingly for biochemical and histological analysis. Prior to euthanasia, peak 
isometric torque of the posterior crural muscles was assessed. 
In vivo functional measurement 
 Animals were weighed and anaesthetized with 2-3% isoflurane with 95-99% oxygen as 
vehicle. The hindlimb was shaved and a skin incision was made to expose the lateral thigh. The 
peroneal nerve was identified and severed to avoid recruitment of the anterior crural muscles. 
The mouse was positioned on a heated platform with its right foot attached to the footpedal 
located on the shaft of the servomotor (model 300B-LR; Aurora Scientific, Aurora, Ontorio, 
Canada). Two platinum electrodes were then inserted subcutaneously on either side of the sciatic 
nerve.  The peak isometric torque was optimized by varying the voltage delivered to the sciatic 
nerve by the stimulator. Torque was then measured by eliciting isometric tetanic contraction at 
	   98 
100 Hz. Measurements were repeated every 90 seconds until a drop in force was detected, with 
no more than 4 trials per animal.  The highest magnitude force measured was recorded and 
expressed relative to body weight of the animal.  The plantaris muscle from the stimulated limb 
was dissected and frozen in liquid nitrogen-cooled isopentane for immunohistochemistry studies 
so as not to impact intracellular signaling as assessed by western blot, whereas the muscle from 
the contralateral limb was directly frozen in liquid nitrogen for western blot analysis.  
Western blotting 
Plantaris muscles were placed directly in 500 µL of ice-cold lysis buffer containing 
HEPES (20 mM), EGTA (2 mM), β-glycerophosphate (50 mM), DTT (1 mM), Na3VO4 (1 mM), 
Triton X-100 (1%), glycerol (10%), leupeptin (10 µM), benzamidine (3 mM), pepstatin A (5 
µM), aprotinin (10 µg/ml), PMSF (1 mM).  The tissue was disrupted using a hand held 
homogenizer (Tissuemiser, Fisher Scientific) and the homogenates were rotated at 4°C for 1 h 
and centrifuged at 14,000g for 5 min at 4°C.  The supernatants were collected and stored at -
80°C. The protein concentration was determined using the Bradford assay with BSA standards as 
reference.   
Equal amounts of protein (25 µg) were resolved by SDS-polyacrylamide gel 
electrophoresis using 6-8% gels and transferred onto nitrocellulose membranes. Equal protein 
loading was verified by Ponceau S staining. The membranes were probed using polyclonal 
primary and HRP-conjugated secondary antibodies. Bands were detected using SuperSignal 
West Dura Extended Duration Substrate (Thermo Scientific, Rockford, IL) and a Bio-Rad 
ChemiDoc XRS system (Bio-Rad, Hercules, CA). Quantification was completed using Quantity 
One software (Bio-Rad). 
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Immunohistochemistry 
Cross sections were obtained from the mid belly of the muscle and fixed in acetone (-
20°C) for 10 minutes.  Sections were stained with anti-myosin heavy chain 1 (BA.D5), anti-
myosin heavy chain 2A (SC.71), anti-myosin heavy chain 2B (BF.F3), and anti-myosin heavy 
chain 2X (6H1) antibodies from the Developmental Studies Hybridoma Bank (Iowa City, IA, 
USA). The sections were also stained with anti-dystrophin (Abcam), anti-collagen (ab21286, 
Abcam), anti-CD11b (BD Biosciences) and anti-α7β1 integrin (CDB 347) primary antibodies 
and Alexa Fluor 633 goat anti rabbit IgG (H+L) (Invitrogen) and FITC goat anti-rat IgG 
(Jackson Immunoresearch) secondary antibodies.  
Images were captured at 10x and 20x magnification using Leica DMRXA2 microscope 
and Axiovision software (Zeiss, Thornwood, NY). Quantification of the collagen content was 
done using Image J as described previously (18). CD11b positive cells co-localizing with DAPI 
were also counted using Image J. To assess myofiber CSA, Adobe Photoshop was used to 
quantitate images acquired with a Zeiss AxioCam digital camera. Briefly, co-stained images of 
dystrophin and type-specific fiber types were acquired at 10x magnification from each sample, 
then imported into Adobe Photoshop (CS5 Extended) where up to 400 fibers per sample were 
manually circled using the magnetic lasso tool, which grabs the positively stained pixels and 
decreases subjectivity and interassessment error. The CSA for each fiber was recorded in a 
measurement log. The results for each sample were then averaged. 
In vitro assessment of myotube growth  
Modulation of substrate.  Untreated Silicon 6-well BioFlex® culture dishes were 
obtained from Flexcell International (Burlington, NC). After a 5 minute ethanol incubation, 10% 
(3-Aminopropyl)triethoxysilane (APTES) was applied to the culture surface for 2 hours at 54°C.  
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After two washes (ddH2O), mouse LM-111 (12.5µg/mL), or LM-111/Collagen 1 (12.5/50µg/mL) 
was mixed with EDC (0.002 g/ml in water), and administered onto the BioFlex® membranes 
overnight at 4°C.  Prior to use, substrates were washed twice (Sterile PBS).  
Myotube alignment and acute strain. Myotubes do not differentiate in an organized 
manner, but are randomly oriented in cell culture. Thus, we developed a protocol to recapitulate 
parallel muscle fiber orientation observed in vivo. C2C12 myoblasts were grown to confluence 
(10% FBS, DMEM) and subjected to 10% uniaxial strain (FX-4000 Tension System, Flexcell 
International) for 2 days upon induction of differentiation (2% HS, DMEM), thus promoting 
alignment perpendicular to the axis of strain as described previously (43).  Differentiation 
occurred in the presence of LM-111 alone or in combination with collagen (n=6/group). After 7 
days of differentiation, aligned myotubes were subject to 20 minutes of 18% acute uniaxial strain 
perpendicular to the direction of strain used during alignment, adapted from a previously 
optimized protocol (22).  
Assessment of myoblast fusion and growth:  Non-overlapping images of the entirety of 
the culture surfaces were obtained 24 hours post-strain (10x magnification, Leica DMRXA2 
microscope and Axiovision software) and imported into Adobe Photoshop (CS5 Extended).  
Myoblast fusion was represented as the number of myotubes counted per image. For each 
myotube, diameter measurements were taken at 3 evenly spaced points along the entire tube and 
averaged. For a branched myotube, the branches were measured as separate myotubes and the 
region where the branches converge was not included. 100 myotubes (70-100 on collagen due to 
less fusion) were measured per well, and average myotube diameter per well was then averaged 
per group.  
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Statistical analysis 
All data is presented as means ± SEM. For the α7 integrin overexpression study, a three-
way ANOVA was performed to determine whether a significant interaction or main effect 
existed between Age, MTE and Genotype.  For the LM-111 study, a two-way ANOVA was 
performed to determine whether a significant interaction or main effect existed between 
Treatment and Age (Treatment factors: sham, saline-MTE, or laminin-MTE).  For fiber 
distribution histograms, statistical analysis was confined to each respective category (Total 
percent fibers distribution: CSA<500µm2, CSA 500-1000µm2, and CSA >2000µm2; Fiber type 
specific frequency distribution and Fiber type specific CSA: Type 1, Type 2A, Type 2B, Type 
2X).  For the in vitro experiment, a two-way ANOVA was performed to determine whether a 
significant interaction or main effect existed between Strain and Substrate.  Differences were 
considered significant at P < 0.05.  A least significant difference (LSD) post-hoc comparison was 
completed across interactions and within main effects to identify the source of significance (P ≤ 
0.05). 
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4.4 Results 
Age disrupts α7 integrin localization at the membrane   
α7 integrin protein expression is increased 2.5-5 fold in 12 mo and 24 mo old 
MHCK7:α7BX2 integrin transgenic (α7Tg) plantaris muscle as compared to age matched WT 
littermates (Genotype Effect, P<0.001) (Figure 4.1A).  In 12 mo WT mice, a trend towards an 
increase in endogenous α7 integrin expression was observed in response to MTE in agreement 
with previous findings, but this was not evident in 24 mo mice (MTE*Age Interaction, P=0.086) 
(6, 15, 35).  A significant increase in plantaris muscle weight was observed post-MTE in 12 mo 
WT mice, which is vastly reduced with age (MTE*Age Interaction, P=0.023) (Figure 4.1B). 
Immunofluorescence analysis demonstrates localization of the α7 integrin at the sarcolemma in 
abundance in 12 mo α7Tg muscle, but staining was either notably absent (24 mo WT) or 
severely compromised in 24 mo α7Tg muscle. Localization also appears to be diffuse within the 
cytoplasm of 24 mo α7Tg muscle, an event that suggests poor α7-ECM binding with age.   
LM-111 administration increases α7 integrin protein expression and sarcolemmal localization 
in aged plantaris muscle 
 An outline of the experimental design is provided in Figure 4.2A.  Immunofluorescence 
analysis confirmed the presence of human laminin α1 protein in mouse skeletal muscle following 
i.p. injection (Figure 4.2B).  No significant change in α7B protein was detected in young 
plantaris in the absence or presence of LM-111 two weeks post-MTE, whereas a significant 
increase was noted in aged muscle with LM-111 administration post-MTE (Treatment*Age 
Interaction, P=0.039) (Figure 4.2C). α7 Integrin localization at the sarcolemma was restored in 
aged muscle with LM-111 treatment post-MTE (Figure 4.2B). Unexpectedly, α7 integrin protein 
	   103 
also co-localized with centrally located nuclei only in aged muscle with LM-111 treatment post-
MTE, suggesting presence of the integrin in the nucleus with treatment (Figure 4.2B). 
LM-111 administration restores the muscle growth response to a mechanical stimulus 
An appropriate increase in plantaris muscle weight was observed in young plantaris with 
saline treatment post-MTE, an event that was vastly suppressed with age.  In accordance with 
increased α7 integrin expression and proper localization at the sarcolemma, LM-111 treatment 
significantly restored the growth response to MTE in aged plantaris  (Treatment*Age Interaction, 
P=0.033) (Figure 4.3A).  The mean CSA of the overloaded plantaris muscles also increased 
significantly compared to sham in both young and aged mice, with seemingly no detectable 
differences with age or LM-111 treatment (Treatment Effect, P=0.016) (Figure 4.3B).  However, 
there was a trend for an increase in the percentage of large caliber fibers (>2000 µm2) in aged 
muscle with LM-111 treatment post-MTE. (Treatment Trend, P=0.088; LSD post hoc: aged-LM-
111 vs aged-sham P=0.048). A corresponding decrease in small caliber fibers (500-2000 µm2) 
was detected in aged muscle post-MTE, however, the prevalence of these fibers were increased 
with age (Age Effect, P=0.003). A decrease in peak force was noted in aged vs. young sham 
mice, however no detectable differences in function were noted in aged muscle with LM-111 
treatment post-MTE (data not shown). 
MTE induces a fiber type shift in young and aged plantaris 
In order to further dissect the changes afforded by LM-111 treatment, fiber type-specific 
CSA was measured, as well as the percentage of fiber types in young and aged muscle (Figure 
4.4).  The CSA of different fiber types in the plantaris muscle is shown in Figure 4.4A. Type 1 
CSA of the young muscle was significantly increased with both saline and LM-111 treatment in 
response to MTE (Type 1: Treatment Effect P=0.043). The CSA of type 2A fibers and Type 2B 
	   104 
fibers were smaller in aged mice, and MTE increased Type 2A CSA (Type 2A: Age Effect, 
P=0.048; Treatment Effect, P=0.002; Type 2B: Age Effect, P=0.032). The CSA of Type 2B and 
2X fibers was not altered in either the young or aged muscle post-MTE.  
The fiber type distribution is shown in Figure 4.4B. The appearance of Type 2A fibers 
was increased and Type 2B fiber contribution was reduced in both young and aged muscle post-
MTE (Type 2A: Treatment Effect, P=0.034; Type 2B: Treatment Effect, P=0.014).  There was a 
trend for an increase in Type 2X fiber composition in aged muscle, and there were no Type I 
fibers present in aged plantaris (Type 2X: Age Trend, P=0.062; Type I: Age Effect, P=0.007).  
LM-111 treatment alters macrophage content and myofiber repair in aged plantaris muscle 
Muscle collagen content and inflammation were evaluated via immunofluorescence 
staining for collagen type 1 and CD11b positive cells, respectively, as shown in Figure 4.5A.  
The percentage area occupied by collagen type 1 increased significantly in both young and old 
plantaris muscles post-MTE with no effect of LM-111 treatment (Treatment Effect, P=0.004).  
The increase compared to sham was exacerbated in the aged plantaris (LSD post hoc: aged-saline 
vs aged sham P=0.004, aged-LM-111 vs aged-sham P=0.016) (Figure 4.5B). The accumulation 
of CD11b positive cells increased significantly in both young and old plantaris muscles post 
MTE, which was exacerbated in the aged group with saline treatment, but was abrogated with 
LM-111 treatment (Treatment Effect, P=0.048).   
Prior studies have demonstrated that chronic overload can elicit muscle damage and a 
subsequent regenerative response in young mice, indicated by an increase in centrally nucleated 
fibers (32, 38).  In agreement, we observed an increase in the frequency of fibers containing 
centrally located nuclei in young and aged muscle following MTE, however, this was reduced in 
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the aged muscle with saline treatment and restored with LM-111 treatment (Treatment Effect, 
P=0.005) (Figure 4.5D).  
Collagen is inhibitory to myoblast fusion and mechanical strain-induced growth in vitro 
 Collagen can accumulate in aged muscle with age. To determine the extent to which 
collagen can directly interfere with laminin-mediated mechanosensing, we examined the growth 
response to uniaxial strain in aligned myotubes in the absence and presence of collagen in the 
substrate (Representative Images, Figure 4.6A).  Myoblast fusion and baseline myotube 
formation was suppressed with the addition of collagen, and mechanical strain did not alter this 
effect (Substrate Effect, P<0.001) (Figure 4.6B). Mean myotube diameter was significantly 
increased in the presence of LM-111 alone, while no growth was observed when collagen was 
incorporated into the substrate (Substrate*Strain Interaction, P=0.008) (Figure 4.6C).  The 
increase in mean myotube diameter on LM-111 was accompanied by a shift in the myotube size 
distribution towards larger tubes (<10 µm: Substrate Effect, P=0.017; 10-20 µm: 
Substrate*Strain Interaction, P=0.010; 20-30 µm: Substrate*Strain Interaction, P=0.005; 30-40 
µm: Substrate Effect, P=0.004) (Figure 4.6D).  
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4.5 Discussion 
Both α7BX2 integrin overexpression and LM-111 supplementation can restore capacity 
for regeneration and ameliorate pathology in mouse models of muscular dystrophy (9, 45). 
Additionally, our lab has demonstrated that α7BX2 integrin overexpression and/or LM-111 can 
promote skeletal muscle repair and growth in young healthy mice in response to acute and 
repeated bouts of eccentric exercise (34, 57, 58).  These results prompted us to investigate the 
extent to which α7BX2 integrin overexpression and LM-111 treatment can initiate repair and 
remodeling in response to a chronic mechanical stimulus in aged skeletal muscle. In the present 
study, we demonstrate that simply overexpressing the α7 integrin does not recover the growth 
response to a mechanical stimulus, likely due to lack of the ability for the integrin to properly 
localize to the sarcolemma. LM-111 administration, in contrast, increased α7 integrin presence at 
the membrane, enhanced the capacity for repair, and restored the anabolic response to chronic 
load.  
Prior to the current study, we aged our colony of MCK:α7BX2 integrin transgenic mice 
for 24 months. Unexpectedly, we found that rat α7B integrin transgene was significantly 
decreased in aged muscle, which we believed was due to loss of MCK enzymatic activity, Type 
2 fibers (preferentially express MCK), or both during the lifespan of the mouse. We created a 
new line of transgenic mice that overexpress the integrin in both Type 1 and Type 2 fibers as a 
result of inclusion of MHCK7 promoter. Integrin protein expression was verified at 12 and 24 
months of age using western blotting. Despite confirmation of expression, we were not able to 
demonstrate a positive outcome associated with the integrin at 24 months, which was odd 
considering the benefits previously reported with α7 integrin overexpression in mice with 
muscular dystrophy. Upon investigation with immunofluorescence methods, it became clear that 
	   107 
the ability for the integrin to localize at the membrane was severely compromised in WT mice to 
a large extent, and the addition of more integrin did not alleviate this deficiency. Integrin staining 
appeared diffuse in the cytoplasm, suggesting that it was present, but not tethered to the basal 
lamina or functional within the muscle fiber. It is not clear why the change in localization 
occurred, but previous studies have observed loss of the dystrophin glycoprotein complex and a 
perturbed sarcolemmal environment in aged rats (21). 
Exogenous administration of LM-111 provides an alternative approach to improving 
regeneration and function of compromised skeletal muscle. LM-111, whether systemically 
administered or directly injected into muscle, can consistently increase endogenous α7B integrin 
subunit expression and prevent contraction- or CTX-induced injury in mdx and dy(W-/-) mouse 
models of muscular dystrophy (45, 53, 57).  In the current study, α7B integrin subunit protein 
expression was not only significantly increased in aged muscle post-MTE, but localization at the 
membrane was restored. Thus, LM-111 administration provides the opportunity to restore 
normal integrin function and sarcolemmal integrity. Whether LM-111 preferentially binds to and 
activates the α7β1 integrin heterodimer in vivo cannot be easily discerned, but likely due to 
previous in vitro studies that demonstrate preferential binding of the integrin to the LM-111 
isoform (12, 56). The mechanism(s) that underlie coordinated expression of laminin and integrin 
expression in muscle are not known, nor do we understand the basis for integrin localization to 
centrally located nuclei in aged mice with LM-111 administration post-MTE.    
Normal, healthy aging can result in changes to the muscle microenvironment that can 
lead to increased membrane damage and deficiencies in stem cell activation (2, 50, 54, 55). 
Traditional synergist ablation and overload can result in damage that initiates a strong 
regenerative response in young muscle (~26% of fibers with a central nuclei), but a defective 
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response in aged muscle (~12%) (32, 38).  In the current study, LM-111 administration did not 
prevent collagen accumulation in the interstitium, which is a hallmark of normal aging, but did 
suppress the inflammatory response and improved indices of repair in aged muscle in response to 
chronic loading (~7% in aged with saline, but ~27% with LM-111 injection). These data are 
consistent with our previous studies that demonstrate the ability for the α7BX2 integrin and LM-
111 to increase satellite cell activation and repair in response to eccentric exercise (34, 57, 58). 
The fact that LM-111 can directly stimulate myogenic stem cell proliferation and differentiation 
in vitro suggests that LM-111 can improve capacity for repair independent of integrin expression 
and/or activation (20, 48, 57).  
The α7 integrin provides an essential role of adhering the ECM (outside the fiber) to the 
actin cytoskeleton (inside the fiber), thus ensuring muscle fiber stabilization and integrity (8).  
However, our work suggests that a secondary role for the integrin is to serve as a mechanosensor 
of external strain during muscle lengthening. Eccentric exercise training can promote significant 
growth and strength in mouse muscle that overexpresses the α7B integrin subunit (58). The 
mechanistic basis by which the integrin can facilitate growth is not well understood, but our 
recent work suggests the ability for the integrin to increase transcription of the LAT1 amino acid 
transporter, phosphorylation of 4E-BP1, and yes-associated protein content (35, 36). Aging is 
concomitant with a reduction in the anabolic response to growth stimuli, including mechanical 
strain (13). In the current study, muscle wet weight was nearly restored in aged muscle with LM-
111 administration two weeks following the onset of chronic loading. A trend towards an 
increase in large caliber fibers was noted, suggesting increased myofibrillar protein synthesis. 
Function as assessed by maximal isometric torque was not altered in response to LM-111 
administration. However, in our model of chronic overload (MTE), the soleus muscle is left 
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intact and its contribution to strength is unknown. It will be important to evaluate soleus weight 
and strength in the future and/or evaluate plantaris force in isolation using an ex vivo approach.  
Despite our inability to accurately measure plantaris strength, this study provides the first report 
of LM-111-mediated promotion of muscle growth in response to chronic loading. Our results 
represent a significant contribution to the field considering the published studies that fail to show 
any recovery and the dearth of effective therapies to overcome anabolic resistance with age (2).      
Variations in physiological parameters such as the muscle type (plantaris, soleus), 
surgical technique (MTE, traditional synergist ablation), animal model or species, animal age, 
and duration of overload make comparisons between published studies difficult. The MTE model 
used in this study distributed load evenly between the plantaris and soleus muscles, in contrast to 
the traditional model where only the plantaris muscle is loaded. Therefore, when compared to the 
majority of other studies, we observed only a modest degree of hypertrophy in the plantaris 
muscle, but believe these results more comparable to the responses observed following resistance 
exercise training (11, 52).  Future studies examining early adaptations and signaling changes in 
response to MTE will allow further elucidation of the mechanisms that allow for LM-111 to 
promote growth in aged muscle.   
Damage can initiate fibroblast-mediated collagen production, which is readily apparent in 
aged and diseased skeletal muscle (23, 26). Collagen deposition is essential for stabilizing 
injured tissue, yet significant accumulation can increase stiffness and delay healing (37). 
Collagen does not interact directly with the α7β1 integrin heterodimer, yet we hypothesized that 
perhaps some of the detrimental impact of collagen on muscle healing is related to its potential to 
interfere with laminin-α7B integrin binding (8). If true, this might provide some insight 
regarding the basis for disrupted integrin localization within the aged sarcolemma. To test this 
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hypothesis, we conducted an in vitro study in which the substrate was modified to incorporate 
either LM-111 alone or LM-111 in combination with collagen. In vitro culture conditions 
prevented the ability to readily evaluate integrin expression at the substrate-membrane interface. 
However, our results demonstrate the ability for collagen to inhibit myoblast fusion and myotube 
development in the absence of mechanical strain, as well as the ability for the myotube to 
hypertrophy in response to an acute mechanical stimulus within 24 hours. The fact that myogenic 
stem cells are not necessary for myotube growth in response strain in vitro also suggests the 
existence of an intrinsic signaling pathway that is solely responsive to strain (38).  Overall, these 
results support the hypothesis that the extracellular matrix provides a significant contribution to 
intrinsic muscle growth response to loading. Use of our newly optimized model of uniaxial strain 
now provides the unique opportunity to further dissect the contribution of a wide variety factors 
in the promotion of muscle growth post-strain.    
In conclusion, the results from this study suggest that α7β1 integrin localization and 
function is impaired in the aged sarcolemma, and that exogenous administration of LM-111 can 
restore integrin expression and ameliorate deficits in repair and the anabolic response to chronic 
loading. Our in vitro data also support the hypothesis that collagen accumulation and subsequent 
interference with LM-α7B integrin binding provides the basis for anabolic resistance to a 
mechanical stimulus. Thus, LM-111 represents a viable therapeutic solution to prevention and 
treatment of sarcopenia. 
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4.9 Figure Legends & Figures 
Figure 4.1 
 
Figure 4.1. Age disrupts α7 integrin localization at the membrane. The MHCK7 promoter for 
overexpression increases α7 integrin protein in the plantaris (A).  Increased muscle weight 2 
weeks post MTE is vastly reduced with age and α7 integrin overexpression does not ameliorate 
this deficit (B).  α7 integrin localization to the sarcolemma post MTE is dysfunctional with age 
(C). *Indicates a genotype main effect (P ≤ 0.05).  # vs 12 and 24 mo sham (P ≤ 0.05). ^ vs. 12 
mo MTE (P ≤ 0.05).  All values are mean ± SEM.  Western blotting data are expressed relative 
to 12 mo sham for each muscle. 
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Figure 4.2 
 
Figure 4.2. LM-111 administration increases α7 integrin protein expression and 
sarcolemmal localization in aged plantaris muscle.  Laminin or Saline was injected one week 
prior to MTE and muscle was evaluated two weeks post-MTE (A).  LM-111 migrates to skeletal 
muscle after i.p. injection, and is detected in the ECM (top panel).  α7 integrin localizes to the 
sarcolemma and centrally located nuclei in aged muscle only with LM-111 treatment post-MTE 
(bottom panel) (B). α7 integrin protein expression in aged plantaris is increased with LM-111 
treatment (C).  ‡ vs all groups (P ≤ 0.05). All values are mean ± SEM.  Data are expressed 
relative to young-sham for each muscle. 
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Figure 4.3 
 
Figure 4.3. LM-111 administration restores the muscle growth response to a mechanical 
stimulus. Muscle weight (A), mean fiber CSA (B), and fiber size frequency distributions (C) are 
presented two weeks post-MTE. * Indicates a Treatment main effect (P ≤ 0.05).  ** Indicates an 
Age main effect (P ≤ 0.05). # vs young and aged sham (P ≤ 0.05). ^ vs. young sham (P ≤ 0.05). § 
vs. aged sham (P ≤ 0.05). ‡ vs all groups (P ≤ 0.05). All values are mean ± SEM.   
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Figure 4.4 
 
Figure 4.4. MTE induces a fiber type shift in young and aged plantaris.  Fiber type-specific 
CSA (A) and fiber frequency plots (B) are presented.  * Indicates a Treatment main effect (P ≤ 
0.05). ** Indicates an Age main effect (P ≤ 0.05). All values are mean ± SEM.   
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Figure 4.5 
 
Figure 4.5. LM-111 administration alters macrophage content and myofiber repair in aged 
plantaris muscle. Collagen type 1 and CD11b+ macrophages were assessed by 
immunohistochemistry (A).  Collagen 1 accumulation (B), CD11b infiltration (C), and CLN 
content (D) were increased with MTE.  * Indicates a Treatment main effect (P ≤ 0.05). # vs young 
and aged sham (P ≤ 0.05). & vs Saline (P ≤ 0.05). All values are mean ± SEM.   
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Figure 4.6 
 
Figure 4.6.  Collagen is inhibitory to myoblast fusion and mechanical strain-induced 
growth in vitro.  C2C12 myoblasts differentiated in the presence of LM-111 only or LM-111 
combined with collagen, and subject to acute uniaxial strain (A).  Myoblast fusion and tube 
development was reduced with the addition of collagen (B), and myotube growth was suppressed 
in response to strain with the addition of collagen (C).  Myotube diameter was increased in the 
presence of LM-111 following strain (D). ** Indicates a Substrate main effect (P ≤ 0.05). ‡ vs all 
groups (P ≤ 0.05).  All values are mean ± SEM.   
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
The overall goal of this dissertation was to determine the extent to which the α7β1 
integrin can regulate remodeling and increases in muscle mass in response to loading in young 
adult and aged mice.  Microarray analysis identified potential mechanisms by which the α7BX2 
integrin influences skeletal muscle remodeling post-eccentric exercise.  The extent to which the 
α7BX2 integrin promotes increased muscle mass in response to chronic overload, as well as 
identification of potential mechanisms by which the α7 integrin facilitates remodeling, were 
revealed through use of myotenectomy (MTE) of the gastrocnemius.  Determination of the extent 
to which α7BX2 integrin overexpression can restore anabolic sensitivity to chronic load in aged 
skeletal muscle was examined, while also exploring therapeutic potential of systemic injection of 
α7 ligand (LM-111).  Lastly, in vitro analysis determined the extent to which extracellular matrix 
proteins dictate the growth response to mechanical strain.  
Microarray analysis suggests the α7β1 integrin facilitates transcription of genes necessary 
for regulation of stress and amino acid transport in skeletal muscle.  Upregulation of the α7BX2 
integrin promotes increased expression of HSPa5/BiP, an important chaperone that can recognize 
and bind unfolded and misfolded proteins.  The α7 integrin directly regulates expression of 
LAT1 (dimer SLC7A5), potentially through promotion of TEA domain family member (TEAD) 
transcription factors.  α7 Integrin overexpression prevents skeletal muscle stress and damage 
associated with MTE while augmenting muscle mass gains. The results from this dissertation 
suggest that α7 integrin-mediated increases in mass do not occur through enhancement of 
mTORC1 signaling 1D post-MTE, but rather via increased phosphorylation of 4E-BP1(Ser65) 
and maintenance of transcriptional co-activator yes-associated protein (YAP) expression.   
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The α7 integrin is a novel therapeutic target for amelioration of sarcopenia.  α7β1 
Integrin localization and function is impaired in the aged sarcolemma, thus overexpression does 
not recover the growth response to a mechanical stimulus.  Administration of exogenous LM-111 
increases α7 integrin presence at the membrane, enhances the capacity for repair, and provides 
restoration of the growth response to chronic load.  In vitro data suggests that collagen 
accumulation and subsequent interference with LM-α7B integrin binding provides the basis for 
anabolic resistance to a mechanical stimulus. Thus, the α7 integrin can mediate skeletal muscle 
remodeling that promotes an increase in muscle mass in response to loading, and its ability to do 
so is likely dependent on the composition of the extracellular matrix.  Further study is necessary 
to investigate the following questions: 
1) What are the intrinsic signaling changes responsible for transmission of α7β1 integrin 
mediated mechanosensing and 4E-BP1(Ser65) phosphorylation? 
2) To what extent is the α7β1 integrin mediated maintenance of YAP expression following MTE 
orchestrated through prevention of phosphorylation and subsequent degradation in the 
cytoplasm? 
3) Is the increase in fiber number per muscle cross section in α7β1 integrin transgenic mice due 
to sarcomere addition or enhanced myogenic stem cell fusion? 
4) What methods can be developed to quantitate α7-ECM binding and integrin activation? 
5) What is the potential for LM-111 to prevent or treat age-related disability?   
 
